(-)-epigallocatechin 3-gallate increases expression EXP 6480464 epigallocatechin gallate results in increased expression of NOS3 mRNA CTD PMID:20021702 , PMID:20706672 (-)-epigallocatechin 3-gallate multiple interactions EXP 6480464 epigallocatechin gallate promotes the reaction [Hydrogen Peroxide results in increased expression of NOS3 mRNA] CTD PMID:20021702 (25R)-cholest-5-ene-3beta,26-diol multiple interactions ISO RGD:10997 6480464 27-hydroxycholesterol inhibits the reaction [Estradiol results in increased expression of NOS3 mRNA] more ... CTD PMID:17873880 (25R)-cholest-5-ene-3beta,26-diol decreases expression ISO RGD:10997 6480464 27-hydroxycholesterol results in decreased expression of NOS3 mRNA CTD PMID:17873880 (R)-carnitine increases expression ISO RGD:3186 6480464 Carnitine results in increased expression of NOS3 CTD PMID:20123095 (R)-lipoic acid multiple interactions ISO RGD:10997 6480464 Thioctic Acid inhibits the reaction [Dietary Fats results in decreased expression of NOS3 mRNA] CTD PMID:27260466 (R,R,R)-alpha-tocopherol increases expression EXP 6480464 alpha-Tocopherol results in increased expression of NOS3 mRNA, alpha-Tocopherol results in increased expression of NOS3 protein CTD PMID:16949522 (S)-nicotine increases expression EXP 6480464 Nicotine results in increased expression of NOS3 mRNA CTD PMID:11166759 1,2-dichloroethane increases expression ISO RGD:10997 6480464 ethylene dichloride results in increased expression of NOS3 mRNA CTD PMID:28189721 1,2-dichloroethane affects expression ISO RGD:10997 6480464 ethylene dichloride affects the expression of NOS3 mRNA CTD PMID:28960355 1,2-dimethylhydrazine increases expression ISO RGD:10997 6480464 1, 2-Dimethylhydrazine results in increased expression of NOS3 mRNA CTD PMID:22206623 1,3-dinitrobenzene increases expression ISO RGD:3186 6480464 3-dinitrobenzene results in increased expression of NOS3 mRNA CTD PMID:21983209 11-deoxycorticosterone decreases phosphorylation ISO RGD:3186 6480464 Desoxycorticosterone results in decreased phosphorylation of NOS3 protein CTD PMID:14993198 11-deoxycorticosterone multiple interactions ISO RGD:3186 6480464 NOS3 protein inhibits the reaction [Desoxycorticosterone results in increased expression of VCAM1 protein] CTD PMID:11834524 11-deoxycorticosterone increases expression ISO RGD:3186 6480464 Desoxycorticosterone results in increased expression of NOS3 protein CTD PMID:16271043 15-deoxy-Delta(12,14)-prostaglandin J2 decreases activity ISO RGD:3186 6480464 15-deoxy-delta(12, 14)-prostaglandin J2 results in decreased activity of NOS3 protein CTD PMID:11890746 17alpha-ethynylestradiol increases expression ISO RGD:10997 6480464 Ethinyl Estradiol results in increased expression of NOS3 mRNA CTD PMID:17942748 17alpha-ethynylestradiol multiple interactions ISO RGD:10997 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of NOS3 mRNA CTD PMID:17942748 17beta-estradiol multiple interactions EXP 6480464 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Progesterone promotes the reaction [Estradiol results in increased activity of NOS3 protein]] more ... CTD PMID:11583108 more ... 17beta-estradiol increases activity EXP 6480464 Estradiol results in increased activity of NOS3 protein CTD PMID:15358673 , PMID:16840783 17beta-estradiol multiple interactions ISO RGD:3186 6480464 5 more ... CTD PMID:11583108 , PMID:15358673 17beta-estradiol affects expression ISO RGD:3186 6480464 Estradiol affects the expression of NOS3 mRNA CTD PMID:12810170 17beta-estradiol increases expression ISO RGD:3186 6480464 Estradiol results in increased expression of NOS3 mRNA, Estradiol results in increased expression of NOS3 protein CTD PMID:11583108 more ... 17beta-estradiol increases expression ISO RGD:10997 6480464 Estradiol results in increased expression of NOS3 mRNA CTD PMID:17873880 17beta-estradiol multiple interactions ISO RGD:10997 6480464 27-hydroxycholesterol inhibits the reaction [Estradiol results in increased expression of NOS3 mRNA] more ... CTD PMID:17873880 , PMID:18628394 17beta-estradiol increases expression EXP 6480464 Estradiol results in increased expression of NOS3 mRNA, Estradiol results in increased expression of NOS3 protein CTD PMID:11583108 , PMID:15358673 2,2',4,4'-Tetrabromodiphenyl ether decreases expression EXP 6480464 2 more ... CTD PMID:31675489 2,3,7,8-tetrachlorodibenzodioxine multiple interactions EXP 6480464 Cycloheximide inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of NOS3 mRNA] CTD PMID:11007951 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:3186 6480464 Tetrachlorodibenzodioxin results in increased expression of NOS3 mRNA CTD PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:3186 6480464 Tetrachlorodibenzodioxin results in decreased expression of NOS3 mRNA CTD PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of NOS3 mRNA CTD PMID:11007951 more ... 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:10997 6480464 Tetrachlorodibenzodioxin affects the expression of NOS3 mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:10997 6480464 Tetrachlorodibenzodioxin results in increased expression of NOS3 mRNA CTD PMID:19933214 , PMID:28213091 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:10997 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of NOS3 mRNA, Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to NOS3 gene] CTD PMID:17942748 , PMID:28213091 2,4,6-tribromophenol decreases expression EXP 6480464 2 more ... CTD PMID:31675489 2,4,6-trinitrotoluene affects expression ISO RGD:3186 6480464 Trinitrotoluene affects the expression of NOS3 mRNA CTD PMID:21346803 2-acetamidofluorene increases expression ISO RGD:10997 6480464 2-Acetylaminofluorene results in increased expression of NOS3 mRNA CTD PMID:17317680 2-acetamidofluorene multiple interactions ISO RGD:10997 6480464 TRP53 protein modified form affects the reaction [2-Acetylaminofluorene results in increased expression of NOS3 mRNA] CTD PMID:17317680 2-butoxyethanol increases expression ISO RGD:10997 6480464 n-butoxyethanol results in increased expression of NOS3 mRNA CTD PMID:19812364 2-hydroxypropanoic acid affects transport EXP 6480464 NOS3 protein affects the transport of Lactic Acid CTD PMID:16032374 22-Hydroxycholesterol decreases expression EXP 6480464 22-hydroxycholesterol results in decreased expression of NOS3 mRNA CTD PMID:19426978 25-hydroxycholesterol decreases expression EXP 6480464 25-hydroxycholesterol results in decreased expression of NOS3 mRNA CTD PMID:19426978 26-hydroxycholesterol multiple interactions ISO RGD:10997 6480464 27-hydroxycholesterol inhibits the reaction [Estradiol results in increased expression of NOS3 mRNA] more ... CTD PMID:17873880 26-hydroxycholesterol decreases expression ISO RGD:10997 6480464 27-hydroxycholesterol results in decreased expression of NOS3 mRNA CTD PMID:17873880 3',5'-cyclic GMP multiple interactions ISO RGD:10997 6480464 NOS3 protein affects the reaction [Ramipril results in increased abundance of Cyclic GMP] CTD PMID:16891913 3',5'-cyclic GMP increases abundance ISO RGD:3186 6480464 NOS3 protein results in increased abundance of Cyclic GMP CTD PMID:11504159 3'-amino-3'-deoxy-N(6),N(6)-dimethyladenosine increases expression ISO RGD:3186 6480464 Puromycin Aminonucleoside results in increased expression of NOS3 mRNA CTD PMID:15039144 3'-amino-3'-deoxy-N(6),N(6)-dimethyladenosine multiple interactions ISO RGD:3186 6480464 Puromycin Aminonucleoside results in decreased expression of and results in decreased activity of NOS3 protein CTD PMID:15039144 3,3',4,4',5-pentachlorobiphenyl multiple interactions EXP 6480464 [Estradiol co-treated with 3 more ... CTD PMID:21513769 3,3',5,5'-tetrabromobisphenol A decreases expression EXP 6480464 tetrabromobisphenol A results in decreased expression of NOS3 protein CTD PMID:31675489 3,3-diphenyl-N-(1-phenylethyl)-1-propanamine decreases activity ISO RGD:3186 6480464 Fendiline results in decreased activity of NOS3 protein CTD PMID:1374468 3-[3-(tert-butylsulfanyl)-1-(4-chlorobenzyl)-5-(propan-2-yl)-1H-indol-2-yl]-2,2-dimethylpropanoic acid multiple interactions EXP 6480464 [fulvestrant co-treated with MK-886] inhibits the reaction [resveratrol results in increased expression of NOS3 mRNA] CTD PMID:21791144 4,4'-sulfonyldiphenol increases expression ISO RGD:10997 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of NOS3 mRNA CTD PMID:30951980 4,4'-sulfonyldiphenol affects methylation ISO RGD:10997 6480464 bis(4-hydroxyphenyl)sulfone affects the methylation of NOS3 gene CTD PMID:31683443 4-hydroxy-TEMPO multiple interactions EXP 6480464 tempol inhibits the reaction [lead acetate results in increased expression of NOS3 protein] CTD PMID:11230275 4-hydroxy-TEMPO multiple interactions ISO RGD:3186 6480464 tempol inhibits the reaction [lead acetate results in increased expression of NOS3 protein], tempol inhibits the reaction [Sodium Chloride results in decreased expression of NOS3 protein] CTD PMID:11454931 , PMID:20232302 5,6,7,8-tetrahydrobiopterin multiple interactions ISO RGD:10997 6480464 [NOS3 protein co-treated with sapropterin deficiency] results in increased chemical synthesis of Superoxides, EPO protein inhibits the reaction [[NOS3 protein co-treated with sapropterin deficiency] results in increased chemical synthesis of Superoxides] CTD PMID:25490417 5,6,7,8-tetrahydrobiopterin multiple interactions EXP 6480464 sapropterin deficiency inhibits the reaction [NOS3 protein results in increased abundance of Superoxides], sapropterin deficiency promotes the reaction [NOS3 protein results in increased abundance of Superoxides] CTD PMID:19011239 5,6,7,8-tetrahydrobiopterin increases activity EXP 6480464 sapropterin results in increased activity of NOS3 protein CTD PMID:23753407 5-(dimethylamino)-N-(3,4-dimethyl-5-isoxazolyl)-1-naphthalenesulfonamide multiple interactions ISO RGD:3186 6480464 5-(dimethylamino)-N-(3, 4-dimethyl-5-isoxazolyl)-1-naphthalenesulfonamide inhibits the reaction [Ouabain results in increased expression of NOS3 protein] CTD PMID:15477225 5-aza-2'-deoxycytidine increases expression EXP 6480464 Decitabine results in increased expression of NOS3 mRNA CTD PMID:16367923 5-fluorouracil multiple interactions ISO RGD:3186 6480464 Bosentan inhibits the reaction [Fluorouracil results in decreased expression of NOS3 protein], Fluorouracil inhibits the reaction [Diethylnitrosamine results in decreased expression of NOS3 mRNA] CTD PMID:31129132 , PMID:34800596 5-fluorouracil decreases expression ISO RGD:3186 6480464 Fluorouracil results in decreased expression of NOS3 protein CTD PMID:34800596 5-methoxypsoralen multiple interactions ISO RGD:3186 6480464 5-Methoxypsoralen inhibits the reaction [Isoproterenol results in decreased phosphorylation of NOS3 protein] CTD PMID:35815753 6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide multiple interactions EXP 6480464 [salvianolic acid co-treated with Glucose] inhibits the reaction [6-chloro-2 more ... CTD PMID:30431688 6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide decreases phosphorylation EXP 6480464 6-chloro-2 more ... CTD PMID:30431688 7,8-Diacetoxy-4-methylcoumarin increases expression EXP 6480464 7, 8-diacetoxy-4-methylcoumarin results in increased expression of NOS3 CTD PMID:24103856 7,9-dihydro-1H-purine-2,6,8(3H)-trione increases abundance ISO RGD:10997 6480464 NOS3 gene mutant form results in increased abundance of Uric Acid CTD PMID:12947532 9,10-phenanthroquinone decreases expression EXP 6480464 9, 10-phenanthrenequinone results in decreased expression of NOS3 protein CTD PMID:34391839 acetylcholine affects response to substance ISO RGD:10997 6480464 NOS3 protein affects the susceptibility to Acetylcholine CTD PMID:17403420 acetylcholine increases phosphorylation ISO RGD:3186 6480464 Acetylcholine results in increased phosphorylation of NOS3 protein CTD PMID:25108154 acetylcholine multiple interactions ISO RGD:3186 6480464 AICA ribonucleotide inhibits the reaction [Palmitic Acid inhibits the reaction [Acetylcholine results in increased phosphorylation of NOS3 protein]] more ... CTD PMID:10954898 , PMID:25108154 acetylcholine increases response to substance ISO RGD:10997 6480464 NOS3 protein results in increased susceptibility to Acetylcholine CTD PMID:15381055 acetylsalicylic acid multiple interactions EXP 6480464 Aspirin inhibits the reaction [Everolimus results in decreased expression of NOS3 protein] more ... CTD PMID:19520256 , PMID:20705923 aflatoxin B1 increases methylation EXP 6480464 Aflatoxin B1 results in increased methylation of NOS3 exon CTD PMID:30157460 Aflatoxin B2 alpha increases methylation EXP 6480464 aflatoxin B2 results in increased methylation of NOS3 intron CTD PMID:30157460 agmatine multiple interactions EXP 6480464 Agmatine inhibits the reaction [Palmitic Acid results in increased activity of and results in decreased phosphorylation of NOS3 protein], dorsomorphin inhibits the reaction [Agmatine inhibits the reaction [Palmitic Acid results in increased activity of and results in decreased phosphorylation of NOS3 protein]] CTD PMID:35747990 AICA ribonucleotide multiple interactions ISO RGD:3186 6480464 AICA ribonucleotide inhibits the reaction [Palmitic Acid inhibits the reaction [Acetylcholine results in increased phosphorylation of NOS3 protein]] CTD PMID:25108154 alcohol multiple interactions EXP 6480464 Adenosine Triphosphate affects the reaction [Alcohols affects the phosphorylation of NOS3 protein], Adenosine Triphosphate inhibits the reaction [Alcohols results in decreased expression of NOS3 protein] CTD PMID:24300283 alcohol decreases expression ISO RGD:3186 6480464 Alcohols results in decreased expression of NOS3 CTD PMID:24300283 alcohol decreases expression EXP 6480464 Alcohols results in decreased expression of NOS3 protein CTD PMID:24300283 alcohol affects phosphorylation EXP 6480464 Alcohols affects the phosphorylation of NOS3 protein CTD PMID:24300283 aldehydo-D-glucose multiple interactions EXP 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Rosiglitazone inhibits the reaction [[Glucose results in decreased phosphorylation of NOS3 protein] which results in increased abundance of Nitric Oxide]] more ... CTD PMID:15490108 more ... aldehydo-D-glucose increases expression EXP 6480464 Glucose results in increased expression of NOS3 mRNA, Glucose results in increased expression of NOS3 protein CTD PMID:10502298 , PMID:15490108 aldehydo-D-glucose decreases phosphorylation EXP 6480464 Glucose results in decreased phosphorylation of NOS3 protein CTD PMID:11696579 more ... aldehydo-D-glucose increases O-linked glycosylation EXP 6480464 Glucose results in increased O-linked glycosylation of NOS3 protein CTD PMID:11696579 aldehydo-D-glucose decreases expression EXP 6480464 Glucose deficiency results in decreased expression of NOS3 protein more ... CTD PMID:15490108 more ... aldehydo-D-glucose increases expression ISO RGD:3186 6480464 Glucose results in increased expression of NOS3 mRNA, Glucose results in increased expression of NOS3 protein CTD PMID:17090780 aldehydo-D-glucose multiple interactions ISO RGD:10997 6480464 Glucose results in decreased expression of and results in decreased phosphorylation of NOS3 protein, pimagedine inhibits the reaction [Glucose results in decreased expression of and results in decreased phosphorylation of NOS3 protein] CTD PMID:18483403 aldrin increases expression EXP 6480464 Aldrin results in increased expression of NOS3 mRNA CTD PMID:28273962 aldrin multiple interactions EXP 6480464 Acetylcysteine inhibits the reaction [Aldrin results in increased expression of NOS3 mRNA] CTD PMID:28273962 alkaloid increases expression ISO RGD:3186 6480464 Alkaloids results in increased expression of NOS3 mRNA CTD PMID:19107738 all-trans-retinoic acid multiple interactions EXP 6480464 Tretinoin promotes the reaction [NOS3 protein results in increased chemical synthesis of Nitric Oxide] CTD PMID:16043647 all-trans-retinoic acid increases phosphorylation EXP 6480464 Tretinoin results in increased phosphorylation of NOS3 protein CTD PMID:16043647 all-trans-retinol increases expression ISO RGD:3186 6480464 Vitamin A deficiency results in increased expression of NOS3 CTD PMID:16036340 allopurinol multiple interactions ISO RGD:3186 6480464 Allopurinol inhibits the reaction [Streptozocin results in decreased phosphorylation of NOS3 protein], Allopurinol promotes the reaction [Acetylcysteine inhibits the reaction [Streptozocin results in decreased phosphorylation of NOS3 protein]] CTD PMID:21912612 alpha-hexachlorocyclohexane increases expression EXP 6480464 alpha-hexachlorocyclohexane results in increased expression of NOS3 mRNA CTD PMID:28273962 alpha-hexachlorocyclohexane multiple interactions EXP 6480464 Acetylcysteine inhibits the reaction [alpha-hexachlorocyclohexane results in increased expression of NOS3 mRNA] CTD PMID:28273962 alpha-Zearalanol multiple interactions EXP 6480464 Zeranol inhibits the reaction [Homocysteine results in decreased expression of NOS3 protein] CTD PMID:16757814 aminoguanidine affects expression ISO RGD:10997 6480464 pimagedine affects the expression of NOS3 mRNA CTD PMID:18483403 aminoguanidine multiple interactions ISO RGD:10997 6480464 pimagedine inhibits the reaction [Glucose results in decreased expression of and results in decreased phosphorylation of NOS3 protein] CTD PMID:18483403 amiodarone multiple interactions EXP 6480464 Amiodarone promotes the reaction [NOS3 protein results in increased chemical synthesis of Nitric Oxide] CTD PMID:16479044 amlodipine increases expression ISO RGD:3186 6480464 Amlodipine results in increased expression of NOS3 mRNA, Amlodipine results in increased expression of NOS3 protein CTD PMID:10445667 , PMID:16392774 ammonium chloride affects expression ISO RGD:3186 6480464 Ammonium Chloride affects the expression of NOS3 mRNA CTD PMID:16483693 ammonium chloride increases expression ISO RGD:3186 6480464 Ammonium Chloride results in increased expression of NOS3 mRNA, Ammonium Chloride results in increased expression of NOS3 protein CTD PMID:16483693 , PMID:23343352 anagliptin multiple interactions EXP 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [anagliptin inhibits the reaction [Hydrogen Peroxide results in decreased expression of NOS3 protein]] more ... CTD PMID:31586451 ANTU decreases expression ISO RGD:3186 6480464 alpha-naphthyl thiourea results in decreased expression of NOS3 mRNA, alpha-naphthyl thiourea results in decreased expression of NOS3 protein CTD PMID:30974023 ANTU multiple interactions ISO RGD:3186 6480464 chrysin inhibits the reaction [alpha-naphthyl thiourea results in decreased expression of NOS3 mRNA] more ... CTD PMID:30974023 apocynin increases expression ISO RGD:3186 6480464 acetovanillone results in increased expression of NOS3 protein CTD PMID:23703608 apocynin multiple interactions EXP 6480464 acetovanillone inhibits the reaction [Glucose results in decreased expression of NOS3 protein] CTD PMID:19878672 apocynin multiple interactions ISO RGD:3186 6480464 [Cadmium co-treated with acetovanillone] results in increased expression of NOS3 protein, acetovanillone inhibits the reaction [Formaldehyde results in increased expression of NOS3 mRNA] CTD PMID:21983654 , PMID:23703608 aristolochic acid A increases expression EXP 6480464 aristolochic acid I results in increased expression of NOS3 mRNA CTD PMID:33212167 arsane multiple interactions ISO RGD:3186 6480464 [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of NOS3 protein more ... CTD PMID:22120977 , PMID:33026618 arsane increases phosphorylation ISO RGD:10997 6480464 Arsenic results in increased phosphorylation of NOS3 protein CTD PMID:30822117 arsane decreases expression EXP 6480464 Arsenic results in decreased expression of NOS3 protein CTD PMID:25110733 arsane affects response to substance EXP 6480464 NOS3 gene polymorphism affects the susceptibility to Arsenic CTD PMID:16076760 arsane decreases activity ISO RGD:3186 6480464 Arsenic results in decreased activity of NOS3 protein CTD PMID:22120977 arsane decreases expression ISO RGD:3186 6480464 Arsenic results in decreased expression of NOS3 mRNA CTD PMID:22120977 arsenic atom affects response to substance EXP 6480464 NOS3 gene polymorphism affects the susceptibility to Arsenic CTD PMID:16076760 arsenic atom increases phosphorylation ISO RGD:10997 6480464 Arsenic results in increased phosphorylation of NOS3 protein CTD PMID:30822117 arsenic atom decreases expression EXP 6480464 Arsenic results in decreased expression of NOS3 protein CTD PMID:25110733 arsenic atom decreases expression ISO RGD:3186 6480464 Arsenic results in decreased expression of NOS3 mRNA CTD PMID:22120977 arsenic atom multiple interactions ISO RGD:3186 6480464 [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of NOS3 protein more ... CTD PMID:22120977 , PMID:33026618 arsenic atom decreases activity ISO RGD:3186 6480464 Arsenic results in decreased activity of NOS3 protein CTD PMID:22120977 arsenite(3-) increases phosphorylation EXP 6480464 arsenite results in increased phosphorylation of NOS3 protein CTD PMID:22244921 arsenite(3-) multiple interactions EXP 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [arsenite results in increased phosphorylation of and results in increased activity of NOS3 protein] more ... CTD PMID:11788791 , PMID:22244921 arsenous acid decreases expression EXP 6480464 Arsenic Trioxide results in decreased expression of NOS3 protein CTD PMID:17559834 arsenous acid increases expression EXP 6480464 Arsenic Trioxide results in increased expression of NOS3 mRNA CTD PMID:20458559 arsenous acid multiple interactions EXP 6480464 Arsenic Trioxide results in increased phosphorylation of and results in increased activity of NOS3 protein CTD PMID:18414637 atorvastatin calcium multiple interactions EXP 6480464 Atorvastatin inhibits the reaction [lipopolysaccharide more ... CTD PMID:21585521 atorvastatin calcium increases expression ISO RGD:3186 6480464 Atorvastatin results in increased expression of NOS3 mRNA, Atorvastatin results in increased expression of NOS3 protein CTD PMID:12490971 more ... atorvastatin calcium multiple interactions ISO RGD:3186 6480464 [Dexamethasone co-treated with Atorvastatin] results in increased expression of NOS3 mRNA more ... CTD PMID:17042910 more ... atorvastatin calcium multiple interactions ISO RGD:10997 6480464 Atorvastatin inhibits the reaction [Homocysteine results in decreased expression of NOS3 mRNA], Atorvastatin inhibits the reaction [Homocysteine results in decreased phosphorylation of NOS3 protein] CTD PMID:20305681 atorvastatin calcium affects response to substance EXP 6480464 NOS3 promoter SNP affects the susceptibility to Atorvastatin CTD PMID:16962929 atorvastatin calcium increases expression EXP 6480464 Atorvastatin results in increased expression of NOS3 mRNA, Atorvastatin results in increased expression of NOS3 protein CTD PMID:16410222 ATP multiple interactions EXP 6480464 Adenosine Triphosphate affects the reaction [Alcohols affects the phosphorylation of NOS3 protein], Adenosine Triphosphate inhibits the reaction [Alcohols results in decreased expression of NOS3 protein] CTD PMID:24300283 atrasentan multiple interactions ISO RGD:3186 6480464 atrasentan inhibits the reaction [[19-oxo-11-deoxycorticosterone acetate co-treated with Potassium Chloride co-treated with Sodium Chloride] results in decreased expression of NOS3 protein] CTD PMID:18823320 atrazine decreases expression EXP 6480464 Atrazine results in decreased expression of NOS3 protein CTD PMID:27431321 atrazine multiple interactions EXP 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Atrazine results in decreased expression of NOS3 protein], U 0126 inhibits the reaction [Atrazine results in decreased expression of NOS3 protein] CTD PMID:27431321 axitinib multiple interactions EXP 6480464 axitinib inhibits the reaction [VEGFA protein results in increased phosphorylation of NOS3 protein] CTD PMID:27044328 azoxystrobin increases expression EXP 6480464 azoxystrobin results in increased expression of NOS3 mRNA CTD PMID:34642769 BAPTA multiple interactions EXP 6480464 1 more ... CTD PMID:23836447 benzo[a]pyrene increases expression ISO RGD:10997 6480464 Benzo(a)pyrene results in increased expression of NOS3 mRNA CTD PMID:21569818 , PMID:32417428 benzo[a]pyrene affects methylation EXP 6480464 Benzo(a)pyrene affects the methylation of NOS3 promoter CTD PMID:27901495 , PMID:30157460 benzo[a]pyrene increases methylation EXP 6480464 Benzo(a)pyrene results in increased methylation of NOS3 5' UTR CTD PMID:27901495 benzo[a]pyrene multiple interactions EXP 6480464 U 0126 inhibits the reaction [Benzo(a)pyrene results in increased phosphorylation of NOS3 protein] CTD PMID:24685774 benzo[a]pyrene increases phosphorylation EXP 6480464 Benzo(a)pyrene results in increased phosphorylation of NOS3 protein CTD PMID:24685774 benzo[a]pyrene increases expression ISO RGD:3186 6480464 Benzo(a)pyrene results in increased expression of NOS3 mRNA CTD PMID:22374506 benzo[a]pyrene affects expression ISO RGD:3186 6480464 Benzo(a)pyrene affects the expression of NOS3 protein CTD PMID:22374506 benzo[a]pyrene diol epoxide I multiple interactions EXP 6480464 7 more ... CTD PMID:28529061 benzo[b]fluoranthene increases expression ISO RGD:10997 6480464 benzo(b)fluoranthene results in increased expression of NOS3 mRNA CTD PMID:26377693 benzo[e]pyrene increases methylation EXP 6480464 benzo(e)pyrene results in increased methylation of NOS3 promoter CTD PMID:30157460 benzoic acid increases expression EXP 6480464 Benzoic Acid results in increased expression of NOS3 mRNA CTD PMID:15740983 beta-naphthoflavone multiple interactions ISO RGD:10997 6480464 [Triclosan co-treated with beta-Naphthoflavone] results in decreased expression of NOS3 protein CTD PMID:33722737 beta-naphthoflavone decreases expression EXP 6480464 beta-Naphthoflavone results in decreased expression of NOS3 mRNA CTD PMID:32858204 beta-naphthoflavone decreases expression ISO RGD:10997 6480464 beta-Naphthoflavone results in decreased expression of NOS3 protein CTD PMID:33722737 bezafibrate multiple interactions ISO RGD:10997 6480464 [Bezafibrate results in increased phosphorylation of NOS3 protein] which results in increased abundance of Nitric Oxide more ... CTD PMID:21499286 bezafibrate increases phosphorylation ISO RGD:10997 6480464 Bezafibrate results in increased phosphorylation of NOS3 protein CTD PMID:21499286 bis(2-chloroethyl) sulfide multiple interactions EXP 6480464 Mustard Gas affects the localization of and results in increased activity of NOS3 protein CTD PMID:19397961 bis(2-ethylhexyl) phthalate decreases phosphorylation ISO RGD:10997 6480464 Diethylhexyl Phthalate results in decreased phosphorylation of NOS3 protein CTD PMID:25995009 bisphenol A increases phosphorylation EXP 6480464 bisphenol A results in increased phosphorylation of NOS3 protein CTD PMID:22045264 bisphenol A decreases methylation EXP 6480464 bisphenol A results in decreased methylation of NOS3 gene CTD PMID:31601247 bisphenol A multiple interactions EXP 6480464 [bisphenol A co-treated with Fulvestrant] results in decreased methylation of NOS3 gene CTD PMID:31601247 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of NOS3 protein CTD PMID:31675489 bisphenol A affects binding EXP 6480464 bisphenol A binds to NOS3 protein CTD PMID:34706627 bisphenol A decreases expression ISO RGD:3186 6480464 bisphenol A results in decreased expression of NOS3 mRNA CTD PMID:30816183 more ... bisphenol A multiple interactions ISO RGD:3186 6480464 [bisphenol A co-treated with Dietary Fats] results in decreased expression of NOS3 protein more ... CTD PMID:27622962 , PMID:31489946 bisphenol A affects expression ISO RGD:3186 6480464 bisphenol A affects the expression of NOS3 mRNA CTD PMID:25181051 bisphenol A increases expression ISO RGD:10997 6480464 bisphenol A results in increased expression of NOS3 mRNA, bisphenol A results in increased expression of NOS3 protein CTD PMID:25103225 more ... bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of NOS3 mRNA, bisphenol A results in increased expression of NOS3 protein CTD PMID:22045264 more ... Bisphenol A diglycidyl ether multiple interactions ISO RGD:3186 6480464 2, 2-bis(4-glycidyloxyphenyl)propane inhibits the reaction [caryophyllene inhibits the reaction [[Dietary Fats co-treated with Fructose] results in decreased expression of NOS3 protein]] CTD PMID:30343038 bisphenol F increases expression ISO RGD:10997 6480464 bisphenol F results in increased expression of NOS3 mRNA CTD PMID:30951980 bosentan multiple interactions ISO RGD:3186 6480464 Bosentan inhibits the reaction [Fluorouracil results in decreased expression of NOS3 protein] CTD PMID:34800596 C60 fullerene increases expression ISO RGD:3186 6480464 fullerene C60 results in increased expression of NOS3 mRNA CTD PMID:19167457 cadmium atom multiple interactions ISO RGD:3186 6480464 [Cadmium co-treated with acetovanillone] results in increased expression of NOS3 protein more ... CTD PMID:16226777 , PMID:23703608 cadmium dichloride decreases expression ISO RGD:10997 6480464 Cadmium Chloride results in decreased expression of NOS3 protein CTD PMID:25502771 cadmium dichloride decreases expression ISO RGD:3186 6480464 Cadmium Chloride results in decreased expression of NOS3 protein CTD PMID:18155860 cadmium dichloride multiple interactions ISO RGD:10997 6480464 tetrahydrocurcumin inhibits the reaction [Cadmium Chloride results in decreased expression of NOS3 protein] CTD PMID:25502771 caffeine multiple interactions ISO RGD:3186 6480464 [Isoproterenol co-treated with Caffeine] results in decreased expression of NOS3 mRNA CTD PMID:29447158 Calcimycin multiple interactions ISO RGD:3186 6480464 [Calcimycin results in increased activity of NOS3 protein] which results in increased abundance of Superoxides more ... CTD PMID:10625313 , PMID:20977430 Calcimycin increases expression EXP 6480464 Calcimycin results in increased expression of NOS3 mRNA CTD PMID:20020783 Calcimycin multiple interactions EXP 6480464 Calcimycin inhibits the reaction [Glycochenodeoxycholic Acid results in decreased expression of NOS3 mRNA] CTD PMID:19837105 , PMID:20020783 Calcimycin increases activity ISO RGD:3186 6480464 Calcimycin results in increased activity of NOS3 protein CTD PMID:11796706 calciol decreases expression ISO RGD:3186 6480464 Cholecalciferol deficiency results in decreased expression of NOS3 protein CTD PMID:29408903 calcitriol decreases expression ISO RGD:3186 6480464 Calcitriol results in decreased expression of NOS3 protein CTD PMID:19092814 calcium atom affects response to substance ISO RGD:10997 6480464 NOS3 protein affects the susceptibility to Calcium CTD PMID:17403420 calcium atom increases activity EXP 6480464 Calcium results in increased activity of NOS3 protein CTD PMID:22244921 calcium atom affects response to substance ISO RGD:3186 6480464 NOS3 protein affects the susceptibility to Calcium CTD PMID:19380615 calcium atom multiple interactions EXP 6480464 Calcium affects the reaction [Polycyclic Aromatic Hydrocarbons results in increased expression of and results in increased activity of NOS3 protein] more ... CTD PMID:15183461 more ... calcium(0) affects response to substance ISO RGD:10997 6480464 NOS3 protein affects the susceptibility to Calcium CTD PMID:17403420 calcium(0) increases activity EXP 6480464 Calcium results in increased activity of NOS3 protein CTD PMID:22244921 calcium(0) affects response to substance ISO RGD:3186 6480464 NOS3 protein affects the susceptibility to Calcium CTD PMID:19380615 calcium(0) multiple interactions EXP 6480464 Calcium affects the reaction [Polycyclic Aromatic Hydrocarbons results in increased expression of and results in increased activity of NOS3 protein] more ... CTD PMID:15183461 more ... calmidazolium decreases activity ISO RGD:3186 6480464 calmidazolium results in decreased activity of NOS3 protein CTD PMID:1374468 camostat increases expression ISO RGD:3186 6480464 camostat results in increased expression of NOS3 mRNA CTD PMID:10458643 candesartan multiple interactions EXP 6480464 [PD 123319 binds to and results in decreased activity of AGTR2 protein] inhibits the reaction [candesartan results in increased expression of NOS3 protein] CTD PMID:18551021 candesartan multiple interactions ISO RGD:3186 6480464 candesartan inhibits the reaction [Streptozocin results in increased expression of NOS3 mRNA], candesartan inhibits the reaction [Streptozocin results in increased expression of NOS3 protein] CTD PMID:16139267 candesartan multiple interactions ISO RGD:10997 6480464 candesartan inhibits the reaction [AGT results in increased expression of NOS3 protein] CTD PMID:12065685 Candesartan cilexetil increases expression ISO RGD:3186 6480464 candesartan cilexetil results in increased expression of NOS3 mRNA CTD PMID:18551021 cantharidin affects expression EXP 6480464 Cantharidin affects the expression of NOS3 mRNA CTD PMID:32726682 capsaicin multiple interactions EXP 6480464 Capsaicin promotes the reaction [resveratrol results in increased expression of NOS3 protein] more ... CTD PMID:19846903 capsaicin decreases expression ISO RGD:3186 6480464 Capsaicin results in decreased expression of NOS3 mRNA CTD PMID:16278290 , PMID:18037908 capsaicin increases expression EXP 6480464 Capsaicin results in increased expression of NOS3 protein CTD PMID:19846903 carbon monoxide multiple interactions ISO RGD:3186 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [[Carbon Monoxide results in increased expression of ADIPOQ protein] which results in increased phosphorylation of NOS3 protein], [Carbon Monoxide results in increased expression of ADIPOQ protein] which results in increased phosphorylation of NOS3 protein CTD PMID:19356108 carbon nanotube increases expression EXP 6480464 Nanotubes, Carbon analog results in increased expression of NOS3 mRNA CTD PMID:25102311 carbon nanotube increases expression ISO RGD:10997 6480464 Nanotubes more ... CTD PMID:25554681 , PMID:25620056 Cardamonin multiple interactions ISO RGD:3186 6480464 cardamonin inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in decreased expression of NOS3 mRNA] CTD PMID:28966130 carvedilol increases expression ISO RGD:3186 6480464 carvedilol results in increased expression of NOS3 mRNA, carvedilol results in increased expression of NOS3 protein CTD PMID:17559835 , PMID:18971572 carvedilol increases phosphorylation ISO RGD:3186 6480464 carvedilol results in increased phosphorylation of NOS3 protein CTD PMID:17559835 carvedilol decreases expression ISO RGD:3186 6480464 carvedilol results in decreased expression of NOS3 mRNA CTD PMID:16741616 cetirizine multiple interactions ISO RGD:10997 6480464 [Cetirizine co-treated with Dietary Fats co-treated with APOE gene mutant form] results in increased expression of NOS3 mRNA CTD PMID:25020133 chelerythrine multiple interactions ISO RGD:3186 6480464 [chelerythrine co-treated with tyrphostin 47] inhibits the reaction [Quercetin results in increased expression of NOS3 protein] CTD PMID:22557973 chlorogenic acid increases expression EXP 6480464 Chlorogenic Acid results in increased expression of NOS3 mRNA CTD PMID:20706672 chlorpyrifos increases expression EXP 6480464 Chlorpyrifos results in increased expression of NOS3 protein CTD PMID:32526215 choline decreases expression ISO RGD:10997 6480464 Choline results in decreased expression of NOS3 protein CTD PMID:27567547 choline multiple interactions ISO RGD:10997 6480464 ursolic acid inhibits the reaction [Choline results in increased expression of NOS3 protein] CTD PMID:27567547 chromium atom multiple interactions ISO RGD:3186 6480464 [Niacin co-treated with Chromium] inhibits the reaction [CAV1 protein binds to NOS3 protein] more ... CTD PMID:17215582 , PMID:19027847 chrysin multiple interactions ISO RGD:3186 6480464 chrysin inhibits the reaction [alpha-naphthyl thiourea results in decreased expression of NOS3 mRNA] CTD PMID:30974023 cilostazol multiple interactions EXP 6480464 cilostazol inhibits the reaction [Everolimus results in decreased expression of NOS3 protein] more ... CTD PMID:19520256 cilostazol increases phosphorylation EXP 6480464 cilostazol results in increased phosphorylation of NOS3 protein CTD PMID:18556572 cis-caffeic acid increases expression EXP 6480464 caffeic acid results in increased expression of NOS3 mRNA CTD PMID:15740983 cisplatin multiple interactions ISO RGD:3186 6480464 [Cisplatin co-treated with Sildenafil Citrate] results in increased expression of NOS3 mRNA, [Cisplatin co-treated with Sildenafil Citrate] results in increased expression of NOS3 protein CTD PMID:19152827 cloricromen multiple interactions ISO RGD:3186 6480464 cloricromen inhibits the reaction [Streptozocin results in increased expression of NOS3 protein] CTD PMID:19279317 cobalt dichloride increases response to substance EXP 6480464 NOS3 promoter modified form results in increased susceptibility to cobaltous chloride CTD PMID:24681424 cobalt dichloride affects phosphorylation EXP 6480464 cobaltous chloride affects the phosphorylation of NOS3 protein CTD PMID:28624453 cobalt dichloride multiple interactions EXP 6480464 Folic Acid inhibits the reaction [cobaltous chloride affects the phosphorylation of NOS3 protein] CTD PMID:28624453 cobalt dichloride increases expression ISO RGD:3186 6480464 cobaltous chloride results in increased expression of NOS3 protein CTD PMID:22982409 cocaine decreases expression EXP 6480464 Cocaine results in decreased expression of NOS3 protein CTD PMID:18813882 cocaine decreases expression ISO RGD:3186 6480464 Cocaine results in decreased expression of NOS3 protein CTD PMID:17420087 cocaine increases expression ISO RGD:3186 6480464 Cocaine results in increased expression of NOS3 protein CTD PMID:19380615 cocaine decreases phosphorylation ISO RGD:3186 6480464 Cocaine results in decreased phosphorylation of NOS3 protein CTD PMID:19380615 cocaine multiple interactions ISO RGD:10997 6480464 FOS protein mutant form inhibits the reaction [Cocaine results in increased expression of NOS3 mRNA] CTD PMID:18355967 cocaine increases expression ISO RGD:10997 6480464 Cocaine results in increased expression of NOS3 mRNA CTD PMID:18355967 coenzyme Q10 multiple interactions EXP 6480464 coenzyme Q10 inhibits the reaction [Lamivudine results in decreased phosphorylation of NOS3 protein] more ... CTD PMID:23640862 curcumin multiple interactions EXP 6480464 Curcumin inhibits the reaction [CXCL12 protein results in increased phosphorylation of NOS3 protein] more ... CTD PMID:18660423 , PMID:23452621 cyanidin cation increases expression EXP 6480464 cyanidin results in increased expression of NOS3 mRNA CTD PMID:15740983 cycloheximide multiple interactions EXP 6480464 Cycloheximide inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of NOS3 mRNA] CTD PMID:11007951 cyclophosphamide decreases activity ISO RGD:3186 6480464 Cyclophosphamide results in decreased activity of NOS3 protein CTD PMID:9006340 cyclophosphamide decreases expression ISO RGD:3186 6480464 Cyclophosphamide results in decreased expression of NOS3 protein CTD PMID:35762198 cyclophosphamide multiple interactions ISO RGD:3186 6480464 Nitroarginine inhibits the reaction [Simvastatin inhibits the reaction [Cyclophosphamide results in decreased expression of NOS3 protein]], Simvastatin inhibits the reaction [Cyclophosphamide results in decreased expression of NOS3 protein] CTD PMID:35762198 cyclophosphamide increases expression ISO RGD:3186 6480464 Cyclophosphamide results in increased expression of NOS3 protein CTD PMID:16125470 cyclosporin A increases expression EXP 6480464 Cyclosporine results in increased expression of NOS3 mRNA CTD PMID:12352326 , PMID:25562108 D-glucose multiple interactions EXP 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Rosiglitazone inhibits the reaction [[Glucose results in decreased phosphorylation of NOS3 protein] which results in increased abundance of Nitric Oxide]] more ... CTD PMID:15490108 more ... D-glucose decreases phosphorylation EXP 6480464 Glucose results in decreased phosphorylation of NOS3 protein CTD PMID:11696579 more ... D-glucose increases O-linked glycosylation EXP 6480464 Glucose results in increased O-linked glycosylation of NOS3 protein CTD PMID:11696579 D-glucose increases expression ISO RGD:3186 6480464 Glucose results in increased expression of NOS3 mRNA, Glucose results in increased expression of NOS3 protein CTD PMID:17090780 D-glucose multiple interactions ISO RGD:10997 6480464 Glucose results in decreased expression of and results in decreased phosphorylation of NOS3 protein, pimagedine inhibits the reaction [Glucose results in decreased expression of and results in decreased phosphorylation of NOS3 protein] CTD PMID:18483403 D-glucose increases expression EXP 6480464 Glucose results in increased expression of NOS3 mRNA, Glucose results in increased expression of NOS3 protein CTD PMID:10502298 , PMID:15490108 D-glucose decreases expression EXP 6480464 Glucose deficiency results in decreased expression of NOS3 protein more ... CTD PMID:15490108 more ... daidzein increases activity EXP 6480464 daidzein results in increased activity of NOS3 protein CTD PMID:16840783 DDE multiple interactions EXP 6480464 Acetylcysteine inhibits the reaction [Dichlorodiphenyl Dichloroethylene results in increased expression of NOS3 mRNA] CTD PMID:28273962 DDE increases expression EXP 6480464 Dichlorodiphenyl Dichloroethylene results in increased expression of NOS3 mRNA CTD PMID:28273962 Decursin multiple interactions ISO RGD:10997 6480464 decursin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of NOS3 protein] CTD PMID:31351099 deguelin decreases expression EXP 6480464 deguelin results in decreased expression of NOS3 protein CTD PMID:19336726 deguelin increases expression EXP 6480464 deguelin results in increased expression of NOS3 mRNA CTD PMID:34642769 dexamethasone multiple interactions ISO RGD:10997 6480464 [Dexamethasone co-treated with Indomethacin] results in decreased expression of NOS3 protein more ... CTD PMID:18030227 , PMID:30940551 dexamethasone decreases expression EXP 6480464 Dexamethasone results in decreased expression of NOS3 protein CTD PMID:23426970 dexamethasone increases expression EXP 6480464 Dexamethasone results in increased expression of NOS3 mRNA CTD PMID:19853017 dexamethasone increases expression ISO RGD:3186 6480464 Dexamethasone results in increased expression of NOS3 mRNA CTD PMID:10484530 dexamethasone decreases expression ISO RGD:3186 6480464 Dexamethasone results in decreased expression of NOS3 mRNA, Dexamethasone results in decreased expression of NOS3 protein CTD PMID:14618091 more ... dexamethasone multiple interactions ISO RGD:3186 6480464 [Dexamethasone co-treated with Atorvastatin] results in increased expression of NOS3 mRNA more ... CTD PMID:17042910 , PMID:20068362 dexamethasone increases response to substance ISO RGD:10997 6480464 NOS3 gene mutant form results in increased susceptibility to Dexamethasone CTD PMID:18030227 dexamethasone decreases expression ISO RGD:10997 6480464 Dexamethasone results in decreased expression of NOS3 mRNA, Dexamethasone results in decreased expression of NOS3 protein CTD PMID:15050533 , PMID:30940551 dextran sulfate multiple interactions ISO RGD:10997 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of NOS3 mRNA CTD PMID:29950665 diallyl disulfide decreases degradation EXP 6480464 diallyl disulfide results in decreased degradation of NOS3 protein CTD PMID:20229525 diallyl disulfide increases expression EXP 6480464 diallyl disulfide results in increased expression of NOS3 protein CTD PMID:20229525 diallyl disulfide multiple interactions EXP 6480464 diallyl disulfide promotes the reaction [NOS3 protein binds to CAV1 protein], wortmannin inhibits the reaction [diallyl disulfide results in increased phosphorylation of NOS3 protein] CTD PMID:20229525 diallyl disulfide increases phosphorylation EXP 6480464 diallyl disulfide results in increased phosphorylation of NOS3 protein CTD PMID:20229525 diallyl trisulfide multiple interactions EXP 6480464 diallyl trisulfide promotes the reaction [NOS3 protein binds to CAV1 protein], wortmannin inhibits the reaction [diallyl trisulfide results in increased phosphorylation of NOS3 protein] CTD PMID:20229525 diallyl trisulfide increases expression EXP 6480464 diallyl trisulfide results in increased expression of NOS3 protein CTD PMID:20229525 diallyl trisulfide increases phosphorylation EXP 6480464 diallyl trisulfide results in increased phosphorylation of NOS3 protein CTD PMID:20229525 diallyl trisulfide decreases degradation EXP 6480464 diallyl trisulfide results in decreased degradation of NOS3 protein CTD PMID:20229525 diarsenic trioxide increases expression EXP 6480464 Arsenic Trioxide results in increased expression of NOS3 mRNA CTD PMID:20458559 diarsenic trioxide multiple interactions EXP 6480464 Arsenic Trioxide results in increased phosphorylation of and results in increased activity of NOS3 protein CTD PMID:18414637 diarsenic trioxide decreases expression EXP 6480464 Arsenic Trioxide results in decreased expression of NOS3 protein CTD PMID:17559834 dibenz[a,h]anthracene increases expression ISO RGD:10997 6480464 1 more ... CTD PMID:26377693 dibenziodolium multiple interactions EXP 6480464 diphenyleneiodonium inhibits the reaction [Oxygen deficiency results in decreased expression of NOS3 protein] CTD PMID:26906511 dibutyl phthalate decreases phosphorylation EXP 6480464 Dibutyl Phthalate results in decreased phosphorylation of NOS3 protein CTD PMID:34902519 dibutyl phthalate decreases expression ISO RGD:3186 6480464 Dibutyl Phthalate results in decreased expression of NOS3 protein CTD PMID:35690178 dibutyl phthalate multiple interactions EXP 6480464 Dibutyl Phthalate results in increased expression of and results in increased phosphorylation of NOS3 protein, Fulvestrant inhibits the reaction [Dibutyl Phthalate results in increased phosphorylation of NOS3 protein] CTD PMID:36089060 dichlorine decreases activity ISO RGD:3186 6480464 Chlorine results in decreased activity of NOS3 protein CTD PMID:21131444 dichlorine decreases expression ISO RGD:3186 6480464 Chlorine results in decreased expression of NOS3 protein CTD PMID:21131444 digitoxin multiple interactions EXP 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Digitoxin results in increased activity of NOS3 protein], Calcium deficiency inhibits the reaction [Digitoxin results in increased activity of NOS3 protein] CTD PMID:19446813 digitoxin increases activity EXP 6480464 Digitoxin results in increased activity of NOS3 protein CTD PMID:19446813 digoxin decreases response to substance ISO RGD:10997 6480464 NOS3 protein results in decreased susceptibility to Digoxin CTD PMID:11761419 diisononyl phthalate decreases expression ISO RGD:10997 6480464 diisononyl phthalate results in decreased expression of NOS3 protein CTD PMID:30940551 diisononyl phthalate multiple interactions ISO RGD:10997 6480464 diisononyl phthalate promotes the reaction [Dexamethasone results in decreased expression of NOS3 protein], Enalapril inhibits the reaction [diisononyl phthalate promotes the reaction [Dexamethasone results in decreased expression of NOS3 protein]] CTD PMID:30940551 dioxygen decreases activity EXP 6480464 Oxygen deficiency results in decreased activity of NOS3 protein CTD PMID:18001528 dioxygen multiple interactions EXP 6480464 3 more ... CTD PMID:23452621 , PMID:26906511 dioxygen increases expression EXP 6480464 Oxygen deficiency results in increased expression of NOS3 mRNA more ... CTD PMID:23424623 , PMID:23452621 dioxygen decreases expression ISO RGD:3186 6480464 Oxygen deficiency results in decreased expression of NOS3 mRNA, Oxygen deficiency results in decreased expression of NOS3 protein CTD PMID:10747003 more ... dioxygen increases expression ISO RGD:3186 6480464 Oxygen deficiency results in increased expression of NOS3 mRNA, Oxygen deficiency results in increased expression of NOS3 protein CTD PMID:10747003 more ... dioxygen multiple interactions ISO RGD:10997 6480464 valsartan inhibits the reaction [Oxygen deficiency results in increased phosphorylation of NOS3 protein] CTD PMID:18436887 dioxygen multiple interactions ISO RGD:3186 6480464 [Oxygen deficiency co-treated with Blood Glucose deficiency] results in decreased expression of NOS3 mRNA more ... CTD PMID:11897773 more ... dioxygen decreases expression EXP 6480464 Oxygen deficiency results in decreased expression of NOS3 mRNA, Oxygen deficiency results in decreased expression of NOS3 protein CTD PMID:18001528 , PMID:26906511 dioxygen increases phosphorylation ISO RGD:10997 6480464 Oxygen deficiency results in increased phosphorylation of NOS3 protein CTD PMID:18436887 dorsomorphin multiple interactions EXP 6480464 dorsomorphin inhibits the reaction [Agmatine inhibits the reaction [Palmitic Acid results in increased activity of and results in decreased phosphorylation of NOS3 protein]] more ... CTD PMID:20580385 more ... dorsomorphin multiple interactions ISO RGD:10997 6480464 dorsomorphin inhibits the reaction [[Bezafibrate results in increased phosphorylation of NOS3 protein] which results in increased abundance of Nitric Oxide], dorsomorphin inhibits the reaction [Bezafibrate results in increased phosphorylation of NOS3 protein] CTD PMID:21499286 doxorubicin multiple interactions ISO RGD:10997 6480464 Doxorubicin results in decreased phosphorylation of and results in increased glutathionylation of NOS3 protein more ... CTD PMID:17638931 , PMID:28608983 doxorubicin multiple interactions ISO RGD:3186 6480464 erucic acid promotes the reaction [Doxorubicin results in increased expression of NOS3 protein] CTD PMID:30142312 doxorubicin increases expression ISO RGD:3186 6480464 Doxorubicin results in increased expression of NOS3 protein CTD PMID:30142312 doxorubicin decreases expression ISO RGD:10997 6480464 Doxorubicin results in decreased expression of NOS3 mRNA CTD PMID:31158416 doxorubicin decreases response to substance ISO RGD:10997 6480464 NOS3 protein results in decreased susceptibility to Doxorubicin CTD PMID:12591762 doxorubicin increases response to substance ISO RGD:10997 6480464 NOS3 protein results in increased susceptibility to Doxorubicin CTD PMID:19308358 doxorubicin affects response to substance ISO RGD:10997 6480464 NOS3 protein affects the susceptibility to Doxorubicin CTD PMID:17638931 edaravone increases expression ISO RGD:3186 6480464 Edaravone results in increased expression of NOS3 mRNA, Edaravone results in increased expression of NOS3 protein CTD PMID:12969758 edaravone decreases degradation EXP 6480464 Edaravone results in decreased degradation of NOS3 mRNA CTD PMID:15721014 elemental selenium increases expression ISO RGD:10997 6480464 Selenium results in increased expression of NOS3 mRNA CTD PMID:28810182 enalapril multiple interactions ISO RGD:3186 6480464 [Enalapril co-treated with eplerenone] results in decreased expression of NOS3 mRNA, Enalapril inhibits the reaction [Nitric Oxide deficiency results in decreased expression of NOS3 protein] CTD PMID:16197366 , PMID:20571278 enalapril multiple interactions ISO RGD:10997 6480464 [paricalcitol co-treated with Enalapril] results in increased expression of NOS3 protein more ... CTD PMID:20720404 , PMID:30940551 enalapril increases expression ISO RGD:10997 6480464 Enalapril results in increased expression of NOS3 protein CTD PMID:20720404 , PMID:25037058 enalapril affects expression ISO RGD:3186 6480464 Enalapril affects the expression of NOS3 mRNA CTD PMID:12176110 , PMID:20571278 endosulfan multiple interactions EXP 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Endosulfan results in increased expression of NOS3 mRNA], Acetylcysteine inhibits the reaction [Endosulfan results in increased expression of NOS3 mRNA] CTD PMID:28273962 , PMID:32044604 endosulfan decreases expression ISO RGD:3186 6480464 Endosulfan results in decreased expression of NOS3 mRNA CTD PMID:31464424 endosulfan increases expression EXP 6480464 Endosulfan results in increased expression of NOS3 mRNA CTD PMID:28273962 , PMID:32044604 enzyme inhibitor decreases expression ISO RGD:3186 6480464 Enzyme Inhibitors results in decreased expression of NOS3 protein CTD PMID:12009427 eplerenone increases expression ISO RGD:3186 6480464 eplerenone results in increased expression of NOS3 mRNA CTD PMID:15974890 eplerenone multiple interactions ISO RGD:3186 6480464 [Enalapril co-treated with eplerenone] results in decreased expression of NOS3 mRNA CTD PMID:20571278 eplerenone increases activity ISO RGD:3186 6480464 eplerenone results in increased activity of NOS3 protein CTD PMID:15974890 eplerenone decreases expression ISO RGD:3186 6480464 eplerenone results in decreased expression of NOS3 mRNA, eplerenone results in decreased expression of NOS3 protein CTD PMID:20571278 equol multiple interactions EXP 6480464 [AG 1879 results in decreased activity of SRC protein] inhibits the reaction [Equol results in increased activity of and results in increased phosphorylation of NOS3 protein] more ... CTD PMID:16840783 , PMID:21300668 erucic acid increases expression ISO RGD:3186 6480464 erucic acid results in increased expression of NOS3 protein CTD PMID:30142312 erucic acid multiple interactions ISO RGD:3186 6480464 erucic acid promotes the reaction [Doxorubicin results in increased expression of NOS3 protein] CTD PMID:30142312 esculetin multiple interactions ISO RGD:3186 6480464 esculetin inhibits the reaction [[Streptozocin co-treated with Dietary Fats] results in decreased expression of NOS3 mRNA], esculetin inhibits the reaction [Dietary Fats results in decreased expression of NOS3 mRNA] CTD PMID:28946194 estriol increases expression EXP 6480464 Estriol results in increased expression of NOS3 mRNA, Estriol results in increased expression of NOS3 protein CTD PMID:12547825 ethanol decreases expression ISO RGD:3186 6480464 Ethanol results in decreased expression of NOS3 protein CTD PMID:18037914 ethanol increases expression ISO RGD:3186 6480464 Ethanol results in increased expression of NOS3 mRNA, Ethanol results in increased expression of NOS3 protein CTD PMID:18284813 , PMID:19615717 ethylene glycol bis(2-aminoethyl)tetraacetic acid decreases expression EXP 6480464 Egtazic Acid results in decreased expression of NOS3, Egtazic Acid results in decreased expression of NOS3 mRNA CTD PMID:19837105 , PMID:20020783 everolimus decreases expression EXP 6480464 Everolimus results in decreased expression of NOS3 protein CTD PMID:19520256 everolimus multiple interactions EXP 6480464 Aspirin inhibits the reaction [Everolimus results in decreased expression of NOS3 protein], Cilostazol inhibits the reaction [Everolimus results in decreased expression of NOS3 protein] CTD PMID:19520256 fenofibrate multiple interactions EXP 6480464 dorsomorphin inhibits the reaction [Fenofibrate results in increased activity of NOS3 protein] more ... CTD PMID:16442496 , PMID:20580385 fenofibrate increases phosphorylation EXP 6480464 Fenofibrate results in increased phosphorylation of NOS3 protein CTD PMID:16442496 , PMID:20580385 fenofibrate increases activity EXP 6480464 Fenofibrate results in increased activity of NOS3 protein CTD PMID:20580385 fenpyroximate increases expression EXP 6480464 fenpyroximate results in increased expression of NOS3 mRNA CTD PMID:34642769 Fexofenadine hydrochloride multiple interactions ISO RGD:10997 6480464 [fexofenadine co-treated with Dietary Fats co-treated with APOE gene mutant form] results in increased expression of NOS3 mRNA CTD PMID:25020133 fipronil increases expression ISO RGD:3186 6480464 fipronil results in increased expression of NOS3 mRNA CTD PMID:31881178 fluoranthene multiple interactions EXP 6480464 1 more ... CTD PMID:15183461 fluoranthene increases expression EXP 6480464 fluoranthene results in increased expression of NOS3 mRNA, fluoranthene results in increased expression of NOS3 protein CTD PMID:15183461 fluorene increases expression EXP 6480464 fluorene results in increased expression of NOS3 mRNA, fluorene results in increased expression of NOS3 protein CTD PMID:15183461 fluorene multiple interactions EXP 6480464 1 more ... CTD PMID:15183461 flutamide multiple interactions ISO RGD:3186 6480464 [Nebivolol co-treated with Flutamide] results in increased expression of NOS3 protein CTD PMID:19962728 fluvastatin multiple interactions ISO RGD:3186 6480464 [fluvastatin co-treated with Valsartan] results in increased expression of NOS3 mRNA CTD PMID:28951255 folic acid multiple interactions EXP 6480464 [Folic Acid co-treated with NG-Nitroarginine Methyl Ester] results in decreased expression of NOS3 protein more ... CTD PMID:17357445 more ... folic acid decreases expression ISO RGD:10997 6480464 Folic Acid results in decreased expression of NOS3 protein CTD PMID:33404076 folic acid multiple interactions ISO RGD:10997 6480464 Folic Acid inhibits the reaction [AGT protein results in decreased expression of NOS3 protein] more ... CTD PMID:24386282 more ... formaldehyde multiple interactions ISO RGD:3186 6480464 acetovanillone inhibits the reaction [Formaldehyde results in increased expression of NOS3 mRNA] more ... CTD PMID:21983654 , PMID:27020608 formaldehyde decreases expression ISO RGD:3186 6480464 Formaldehyde results in decreased expression of NOS3 mRNA CTD PMID:24844129 , PMID:27020608 formaldehyde increases expression ISO RGD:3186 6480464 Formaldehyde results in increased expression of NOS3 mRNA CTD PMID:21983654 formic acid increases activity ISO RGD:3186 6480464 formic acid results in increased activity of NOS3 protein CTD PMID:31199930 formic acid increases expression ISO RGD:3186 6480464 formic acid results in increased expression of NOS3 mRNA, formic acid results in increased expression of NOS3 protein CTD PMID:31199930 formononetin increases expression ISO RGD:3186 6480464 formononetin results in increased expression of NOS3 mRNA CTD PMID:19570671 formononetin multiple interactions ISO RGD:3186 6480464 formononetin results in increased phosphorylation of and results in increased activity of NOS3 protein CTD PMID:19570671 fosinopril affects expression ISO RGD:3186 6480464 Fosinopril affects the expression of NOS3 mRNA, Fosinopril affects the expression of NOS3 protein CTD PMID:18209565 fructose multiple interactions ISO RGD:3186 6480464 2 more ... CTD PMID:15752949 more ... fructose decreases phosphorylation ISO RGD:3186 6480464 Fructose results in decreased phosphorylation of NOS3 protein CTD PMID:25108154 fructose decreases expression ISO RGD:3186 6480464 Fructose results in decreased expression of NOS3 mRNA, Fructose results in decreased expression of NOS3 protein CTD PMID:15752949 , PMID:26488877 fructose decreases activity ISO RGD:3186 6480464 Fructose results in decreased activity of NOS3 protein CTD PMID:10580434 fructose decreases expression EXP 6480464 Fructose results in decreased expression of NOS3 protein CTD PMID:18508964 fulvestrant multiple interactions EXP 6480464 [bisphenol A co-treated with Fulvestrant] results in decreased methylation of NOS3 gene more ... CTD PMID:14742696 more ... fulvestrant multiple interactions ISO RGD:3186 6480464 fulvestrant inhibits the reaction [Estradiol results in increased expression of NOS3 protein] CTD PMID:11583108 fulvestrant decreases expression ISO RGD:3186 6480464 fulvestrant results in decreased expression of NOS3 protein CTD PMID:19962728 furosemide affects expression ISO RGD:3186 6480464 Furosemide affects the expression of NOS3 mRNA CTD PMID:16526316 genistein increases activity EXP 6480464 Genistein results in increased activity of NOS3 protein CTD PMID:16840783 genistein decreases expression EXP 6480464 Genistein results in decreased expression of NOS3 mRNA CTD PMID:20021702 genistein multiple interactions EXP 6480464 Genistein inhibits the reaction [Hydrogen Peroxide results in increased expression of NOS3 mRNA] more ... CTD PMID:20021702 , PMID:23452621 genistein increases expression EXP 6480464 Genistein results in increased expression of NOS3 mRNA CTD PMID:20706672 gentamycin multiple interactions ISO RGD:10997 6480464 [Gentamicins results in increased expression of DMD protein mutant form] which affects the expression of NOS3 protein CTD PMID:14751810 gentamycin increases expression ISO RGD:3186 6480464 Gentamicins results in increased expression of NOS3 protein CTD PMID:14986132 , PMID:15936777 gentamycin increases expression ISO RGD:10997 6480464 Gentamicins results in increased expression of NOS3 protein CTD PMID:14751810 ginsenoside Re increases phosphorylation EXP 6480464 ginsenoside Re results in increased phosphorylation of NOS3 protein CTD PMID:17490654 ginsenoside Re multiple interactions EXP 6480464 2-aminoethoxydiphenyl borate inhibits the reaction [ginsenoside Re results in increased phosphorylation of NOS3 protein] more ... CTD PMID:17490654 Ginsenoside Rg5 increases expression ISO RGD:3186 6480464 ginsenoside Rg5 results in increased expression of NOS3 CTD PMID:29298510 gliclazide increases expression ISO RGD:3186 6480464 Gliclazide results in increased expression of NOS3 protein CTD PMID:14871415 glucose multiple interactions EXP 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Rosiglitazone inhibits the reaction [[Glucose results in decreased phosphorylation of NOS3 protein] which results in increased abundance of Nitric Oxide]] more ... CTD PMID:15490108 more ... glucose decreases phosphorylation EXP 6480464 Glucose results in decreased phosphorylation of NOS3 protein CTD PMID:11696579 more ... glucose increases O-linked glycosylation EXP 6480464 Glucose results in increased O-linked glycosylation of NOS3 protein CTD PMID:11696579 glucose increases expression ISO RGD:3186 6480464 Glucose results in increased expression of NOS3 mRNA, Glucose results in increased expression of NOS3 protein CTD PMID:17090780 glucose multiple interactions ISO RGD:10997 6480464 Glucose results in decreased expression of and results in decreased phosphorylation of NOS3 protein, pimagedine inhibits the reaction [Glucose results in decreased expression of and results in decreased phosphorylation of NOS3 protein] CTD PMID:18483403 glucose increases expression EXP 6480464 Glucose results in increased expression of NOS3 mRNA, Glucose results in increased expression of NOS3 protein CTD PMID:10502298 , PMID:15490108 glucose decreases expression EXP 6480464 Glucose deficiency results in decreased expression of NOS3 protein more ... CTD PMID:15490108 more ... glycochenodeoxycholic acid decreases expression EXP 6480464 Glycochenodeoxycholic Acid results in decreased expression of NOS3 more ... CTD PMID:19837105 , PMID:20020783 glycochenodeoxycholic acid multiple interactions EXP 6480464 [Glycochenodeoxycholic Acid results in decreased expression of NOS3 protein] which results in decreased abundance of Nitric Oxide more ... CTD PMID:19837105 , PMID:20020783 GW 501516 multiple interactions EXP 6480464 GW 501516 inhibits the reaction [APP gene mutant form results in decreased phosphorylation of NOS3 protein] CTD PMID:22886847 hemin multiple interactions ISO RGD:3186 6480464 [Nitroglycerin co-treated with Hemin] results in increased expression of NOS3 mRNA CTD PMID:17541025 hexachlorobenzene affects expression EXP 6480464 Hexachlorobenzene affects the expression of NOS3 protein CTD PMID:32526215 hexachlorobenzene decreases expression ISO RGD:3186 6480464 Hexachlorobenzene results in decreased expression of NOS3 protein CTD PMID:29277037 hexacosan-1-ol multiple interactions ISO RGD:3186 6480464 1-hexacosanol inhibits the reaction [Streptozocin results in decreased expression of NOS3 protein] CTD PMID:18528636 hexadecanoic acid multiple interactions EXP 6480464 3 more ... CTD PMID:25815690 , PMID:35747990 hexadecanoic acid multiple interactions ISO RGD:3186 6480464 AICA ribonucleotide inhibits the reaction [Palmitic Acid inhibits the reaction [Acetylcholine results in increased phosphorylation of NOS3 protein]] more ... CTD PMID:25108154 high-density lipoprotein cholesterol decreases degradation EXP 6480464 Cholesterol, HDL results in decreased degradation of NOS3 protein CTD PMID:12821261 high-density lipoprotein cholesterol increases expression EXP 6480464 Cholesterol, HDL results in increased expression of NOS3 protein CTD PMID:12094204 high-density lipoprotein cholesterol multiple interactions EXP 6480464 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Cholesterol more ... CTD PMID:12821261 histamine multiple interactions ISO RGD:3186 6480464 Histamine inhibits the reaction [decamethrin results in decreased expression of NOS3 protein] CTD PMID:25299849 homocysteine decreases expression ISO RGD:10997 6480464 Homocysteine results in decreased expression of NOS3 mRNA CTD PMID:20305681 homocysteine multiple interactions ISO RGD:10997 6480464 Atorvastatin inhibits the reaction [Homocysteine results in decreased expression of NOS3 mRNA], Atorvastatin inhibits the reaction [Homocysteine results in decreased phosphorylation of NOS3 protein] CTD PMID:20305681 homocysteine multiple interactions EXP 6480464 Folic Acid inhibits the reaction [Homocysteine results in decreased expression of and results in decreased activity of NOS3 protein] more ... CTD PMID:16757814 , PMID:17357445 homocysteine decreases expression EXP 6480464 Homocysteine results in decreased expression of NOS3 mRNA, Homocysteine results in decreased expression of NOS3 protein CTD PMID:16757814 , PMID:17357445 homocysteine decreases phosphorylation ISO RGD:10997 6480464 Homocysteine results in decreased phosphorylation of NOS3 protein CTD PMID:20305681 hydrochlorothiazide multiple interactions ISO RGD:3186 6480464 Hydrochlorothiazide inhibits the reaction [Nitric Oxide deficiency results in decreased expression of NOS3 protein] CTD PMID:16197366 hydrogen chloride decreases expression ISO RGD:3186 6480464 Hydrochloric Acid results in decreased expression of NOS3 protein CTD PMID:12771618 hydrogen peroxide multiple interactions EXP 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [anagliptin inhibits the reaction [Hydrogen Peroxide results in decreased expression of NOS3 protein]] more ... CTD PMID:18234130 more ... hydrogen peroxide decreases activity EXP 6480464 Hydrogen Peroxide results in decreased activity of NOS3 protein CTD PMID:22358095 , PMID:23639522 hydrogen peroxide increases expression EXP 6480464 Hydrogen Peroxide results in increased expression of NOS3 mRNA, Hydrogen Peroxide results in increased expression of NOS3 protein CTD PMID:14607919 more ... hydrogen peroxide decreases expression EXP 6480464 Hydrogen Peroxide results in decreased expression of NOS3 mRNA, Hydrogen Peroxide results in decreased expression of NOS3 protein CTD PMID:19105596 more ... icariin increases expression EXP 6480464 icariin results in increased expression of NOS3 mRNA CTD PMID:17499557 icariin increases expression ISO RGD:3186 6480464 icariin results in increased expression of NOS3 mRNA, icariin results in increased expression of NOS3 protein CTD PMID:15329286 icariin multiple interactions EXP 6480464 icariin promotes the reaction [NOS3 protein results in increased chemical synthesis of Nitric Oxide], icariin results in increased expression of and results in increased activity of NOS3 protein CTD PMID:17499557 indometacin decreases activity ISO RGD:3186 6480464 Indomethacin results in decreased activity of NOS3 protein CTD PMID:25110317 indometacin multiple interactions ISO RGD:3186 6480464 Indomethacin inhibits the reaction [Formaldehyde results in increased expression of NOS3 mRNA] CTD PMID:21983654 indometacin increases expression ISO RGD:3186 6480464 Indomethacin results in increased expression of NOS3 protein CTD PMID:15053815 indometacin increases expression ISO RGD:10997 6480464 Indomethacin results in increased expression of NOS3 mRNA CTD PMID:18297107 indometacin decreases expression ISO RGD:10997 6480464 Indomethacin results in decreased expression of NOS3 protein CTD PMID:18030227 indometacin multiple interactions ISO RGD:10997 6480464 [Dexamethasone co-treated with Indomethacin] results in decreased expression of NOS3 protein CTD PMID:18030227 iron dextran decreases phosphorylation EXP 6480464 Iron-Dextran Complex results in decreased phosphorylation of NOS3 protein CTD PMID:32135237 iron dextran multiple interactions ISO RGD:3186 6480464 Iron-Dextran Complex results in increased expression of and results in increased phosphorylation of NOS3 protein CTD PMID:29990562 iron dextran multiple interactions EXP 6480464 Arginine inhibits the reaction [Iron-Dextran Complex results in decreased phosphorylation of NOS3 protein] more ... CTD PMID:32135237 isoprenaline multiple interactions ISO RGD:3186 6480464 3-(2-ethylphenoxy)-1-(1 more ... CTD PMID:17996136 more ... isoprenaline decreases phosphorylation ISO RGD:3186 6480464 Isoproterenol results in decreased phosphorylation of NOS3 protein CTD PMID:35815753 isoprenaline increases expression ISO RGD:3186 6480464 Isoproterenol results in increased expression of NOS3 mRNA, Isoproterenol results in increased expression of NOS3 protein CTD PMID:16702995 more ... isoprenaline decreases expression ISO RGD:3186 6480464 Isoproterenol results in decreased expression of NOS3 mRNA, Isoproterenol results in decreased expression of NOS3 protein CTD PMID:18816294 more ... isoprenaline affects response to substance ISO RGD:10997 6480464 NOS3 protein affects the susceptibility to Isoproterenol CTD PMID:17403420 isoprenaline multiple interactions ISO RGD:10997 6480464 NOS3 inhibits the reaction [Isoproterenol results in increased expression of NPPA mRNA] CTD PMID:12224825 isorhamnetin multiple interactions EXP 6480464 3-methylquercetin inhibits the reaction [Lipids results in decreased expression of NOS3] CTD PMID:16891912 isosorbide dinitrate multiple interactions EXP 6480464 [Isosorbide Dinitrate co-treated with Ascorbic Acid] affects the expression of NOS3 mRNA, [Isosorbide Dinitrate co-treated with Plant Preparations] results in increased expression of NOS3 mRNA CTD PMID:15719745 kaempferol multiple interactions ISO RGD:3186 6480464 [kaempferol inhibits the reaction [Lipopolysaccharides co-treated with TNF protein]] which results in increased expression of NOS3 protein CTD PMID:36049518 L-arginine multiple interactions EXP 6480464 Arginine inhibits the reaction [Iron-Dextran Complex results in decreased phosphorylation of NOS3 protein] CTD PMID:32135237 L-ascorbic acid multiple interactions ISO RGD:3186 6480464 [Vitamin E co-treated with Ascorbic Acid] inhibits the reaction [Dexamethasone results in decreased expression of NOS3 protein] more ... CTD PMID:11729227 more ... L-ascorbic acid increases activity EXP 6480464 Ascorbic Acid results in increased activity of NOS3 protein CTD PMID:11243424 L-ascorbic acid increases phosphorylation ISO RGD:10997 6480464 Ascorbic Acid results in increased phosphorylation of NOS3 protein CTD PMID:21570463 L-ascorbic acid multiple interactions EXP 6480464 [Isosorbide Dinitrate co-treated with Ascorbic Acid] affects the expression of NOS3 mRNA CTD PMID:15719745 L-erythro-7,8-dihydrobiopterin multiple interactions EXP 6480464 7, 8-dihydrobiopterin promotes the reaction [NOS3 protein results in increased abundance of Superoxides] CTD PMID:19011239 lamivudine multiple interactions EXP 6480464 coenzyme Q10 inhibits the reaction [Lamivudine results in decreased phosphorylation of NOS3 protein] CTD PMID:23640862 lamivudine decreases phosphorylation EXP 6480464 Lamivudine results in decreased phosphorylation of NOS3 protein CTD PMID:23640862 lead diacetate increases expression EXP 6480464 lead acetate results in increased expression of NOS3 protein CTD PMID:11230275 lead diacetate decreases expression ISO RGD:3186 6480464 lead acetate results in decreased expression of NOS3 protein CTD PMID:30980911 lead diacetate decreases expression ISO RGD:10997 6480464 lead acetate results in decreased expression of NOS3 protein CTD PMID:23501611 , PMID:23855546 lead diacetate multiple interactions ISO RGD:10997 6480464 puerarin inhibits the reaction [lead acetate results in decreased expression of NOS3 protein], Quercetin inhibits the reaction [lead acetate results in decreased expression of NOS3 protein] CTD PMID:23501611 , PMID:23855546 lead diacetate increases expression ISO RGD:3186 6480464 lead acetate results in increased expression of NOS3 protein CTD PMID:11454931 , PMID:11729227 lead diacetate multiple interactions ISO RGD:3186 6480464 Ascorbic Acid inhibits the reaction [lead acetate results in increased expression of NOS3 protein] more ... CTD PMID:11454931 more ... lead diacetate multiple interactions EXP 6480464 tempol inhibits the reaction [lead acetate results in increased expression of NOS3 protein], U 74389F inhibits the reaction [lead acetate results in increased expression of NOS3 protein] CTD PMID:11230275 lead(0) increases expression ISO RGD:3186 6480464 Lead results in increased expression of NOS3 protein CTD PMID:10523326 lead(0) increases phosphorylation ISO RGD:3186 6480464 Lead results in increased phosphorylation of NOS3 protein CTD PMID:21364929 lead(0) multiple interactions ISO RGD:3186 6480464 Vitamin E inhibits the reaction [Lead results in increased expression of NOS3 protein] CTD PMID:10523326 lead(2+) increases phosphorylation ISO RGD:3186 6480464 Lead results in increased phosphorylation of NOS3 protein CTD PMID:21364929 lead(2+) multiple interactions ISO RGD:3186 6480464 Vitamin E inhibits the reaction [Lead results in increased expression of NOS3 protein] CTD PMID:10523326 lead(2+) increases expression ISO RGD:3186 6480464 Lead results in increased expression of NOS3 protein CTD PMID:10523326 lead(II) chloride decreases expression EXP 6480464 lead chloride results in decreased expression of NOS3 mRNA, lead chloride results in decreased expression of NOS3 protein CTD PMID:25410796 levamisole decreases expression EXP 6480464 Levamisole results in decreased expression of NOS3 protein CTD PMID:11139434 linoleic acid decreases expression EXP 6480464 Linoleic Acid results in decreased expression of NOS3 mRNA CTD PMID:16895544 lipoic acid multiple interactions ISO RGD:10997 6480464 Thioctic Acid inhibits the reaction [Dietary Fats results in decreased expression of NOS3 mRNA] CTD PMID:27260466 lipopolysaccharide multiple interactions ISO RGD:10997 6480464 ESR1 protein affects the reaction [Lipopolysaccharides affects the expression of NOS3 mRNA] more ... CTD PMID:17158209 , PMID:23170834 lipopolysaccharide decreases expression ISO RGD:10997 6480464 Lipopolysaccharides results in decreased expression of NOS3 protein CTD PMID:23170834 lipopolysaccharide multiple interactions ISO RGD:3186 6480464 [kaempferol inhibits the reaction [Lipopolysaccharides co-treated with TNF protein]] which results in increased expression of NOS3 protein more ... CTD PMID:15583003 , PMID:36049518 lipopolysaccharide multiple interactions EXP 6480464 Lipopolysaccharides promotes the reaction [Nickel results in decreased expression of [NOS3 protein binds to NOS3 protein]] CTD PMID:23788629 losartan affects expression ISO RGD:3186 6480464 Losartan affects the expression of NOS3 mRNA CTD PMID:12198324 losartan increases expression ISO RGD:3186 6480464 Losartan results in increased expression of NOS3 mRNA CTD PMID:18971572 , PMID:23091284 losartan multiple interactions ISO RGD:3186 6480464 [Losartan co-treated with Atorvastatin] results in increased expression of NOS3 mRNA, Losartan inhibits the reaction [Sodium Chloride results in decreased expression of NOS3 protein] CTD PMID:20232302 , PMID:23091284 losartan increases phosphorylation ISO RGD:3186 6480464 Losartan results in increased phosphorylation of NOS3 protein CTD PMID:18390819 luteolin multiple interactions ISO RGD:3186 6480464 [Luteolin co-treated with linarin] results in increased expression of NOS3 protein modified form CTD PMID:29052401 LY294002 multiple interactions EXP 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [(4-(((2-(3-fluoro-4-(trifluoromethyl)phenyl)-4-methyl-1 more ... CTD PMID:11788791 more ... LY294002 multiple interactions ISO RGD:3186 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [[Carbon Monoxide results in increased expression of ADIPOQ protein] which results in increased phosphorylation of NOS3 protein] CTD PMID:19356108 lysophosphatidylcholine multiple interactions ISO RGD:3186 6480464 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Lysophosphatidylcholines results in decreased expression of NOS3 mRNA], resveratrol inhibits the reaction [Lysophosphatidylcholines results in decreased expression of NOS3 mRNA] CTD PMID:20564508 lysophosphatidylcholine decreases expression ISO RGD:3186 6480464 Lysophosphatidylcholines results in decreased expression of NOS3 mRNA CTD PMID:20564508 Magnolol multiple interactions ISO RGD:3186 6480464 magnolol inhibits the reaction [Monocrotaline results in decreased expression of NOS3 protein] CTD PMID:30466619 manganese atom multiple interactions EXP 6480464 Manganese inhibits the reaction [Equol results in increased activity of and results in increased phosphorylation of NOS3 protein] CTD PMID:21300668 manganese(0) multiple interactions EXP 6480464 Manganese inhibits the reaction [Equol results in increased activity of and results in increased phosphorylation of NOS3 protein] CTD PMID:21300668 manganese(II) chloride multiple interactions ISO RGD:10997 6480464 [Plant Extracts co-treated with manganese chloride] affects the expression of NOS3 protein CTD PMID:26064043 manidipine increases expression ISO RGD:3186 6480464 manidipine results in increased expression of NOS3 mRNA, manidipine results in increased expression of NOS3 protein CTD PMID:16392774 masoprocol multiple interactions EXP 6480464 Masoprocol inhibits the reaction [Ritonavir results in decreased expression of NOS3 mRNA] CTD PMID:22037733 medroxyprogesterone acetate multiple interactions EXP 6480464 Medroxyprogesterone Acetate inhibits the reaction [Estradiol results in increased activity of NOS3 protein], Medroxyprogesterone Acetate inhibits the reaction [Estradiol results in increased expression of NOS3 protein] CTD PMID:15358673 medroxyprogesterone acetate multiple interactions ISO RGD:3186 6480464 Medroxyprogesterone Acetate inhibits the reaction [Estradiol results in increased expression of NOS3 protein] CTD PMID:15358673 melatonin multiple interactions EXP 6480464 Melatonin inhibits the reaction [lipopolysaccharide more ... CTD PMID:21585521 menadione decreases activity ISO RGD:3186 6480464 Vitamin K 3 results in decreased activity of NOS3 protein CTD PMID:11551532 mercury dichloride decreases expression ISO RGD:3186 6480464 Mercuric Chloride results in decreased expression of NOS3 mRNA, Mercuric Chloride results in decreased expression of NOS3 protein CTD PMID:9788586 , PMID:9853001 metformin multiple interactions EXP 6480464 [Orotic Acid inhibits the reaction [Metformin results in increased phosphorylation of NOS3 protein]] which results in decreased abundance of Nitric Oxide, Orotic Acid inhibits the reaction [Metformin results in increased phosphorylation of NOS3 protein] CTD PMID:25601987 metformin multiple interactions ISO RGD:3186 6480464 Metformin inhibits the reaction [Fructose results in decreased phosphorylation of NOS3 protein], Metformin inhibits the reaction [Palmitic Acid inhibits the reaction [Acetylcholine results in increased phosphorylation of NOS3 protein]] CTD PMID:25108154 methacholine chloride decreases response to substance ISO RGD:10997 6480464 NOS3 gene mutant form results in decreased susceptibility to Methacholine Chloride CTD PMID:22421449 methacholine chloride multiple interactions ISO RGD:10997 6480464 N-(oxo-5 more ... CTD PMID:22421449 methapyrilene increases methylation EXP 6480464 Methapyrilene results in increased methylation of NOS3 promoter CTD PMID:30157460 methotrexate affects response to substance EXP 6480464 NOS3 gene SNP affects the susceptibility to Methotrexate CTD PMID:16013960 methotrexate decreases expression EXP 6480464 Methotrexate results in decreased expression of NOS3 mRNA CTD PMID:24449571 methotrexate increases expression EXP 6480464 Methotrexate results in increased expression of NOS3 mRNA CTD PMID:21678067 metoprolol decreases expression ISO RGD:3186 6480464 Metoprolol results in decreased expression of NOS3 protein CTD PMID:18703049 mevalonic acid multiple interactions EXP 6480464 Mevalonic Acid inhibits the reaction [Simvastatin results in increased expression of NOS3 mRNA], Mevalonic Acid inhibits the reaction [Y 27632 results in increased phosphorylation of NOS3 protein] CTD PMID:17322126 , PMID:20493886 mifepristone multiple interactions EXP 6480464 Mifepristone inhibits the reaction [ginsenoside Re results in increased phosphorylation of NOS3 protein] more ... CTD PMID:15358673 more ... mifepristone decreases expression EXP 6480464 Mifepristone results in decreased expression of NOS3 protein CTD PMID:18710710 miquelianin multiple interactions EXP 6480464 quercetin 3-O-glucuronide inhibits the reaction [Palmitates inhibits the reaction [INS protein results in increased phosphorylation of NOS3 protein]] CTD PMID:23504962 MK-2206 multiple interactions ISO RGD:3186 6480464 [MK 2206 inhibits the reaction [Lipopolysaccharides co-treated with TNF protein]] which results in increased expression of NOS3 protein CTD PMID:36049518 monocrotaline decreases activity ISO RGD:3186 6480464 Monocrotaline results in decreased activity of NOS3 protein CTD PMID:16225752 monocrotaline decreases expression ISO RGD:3186 6480464 Monocrotaline results in decreased expression of NOS3 mRNA, Monocrotaline results in decreased expression of NOS3 protein CTD PMID:25460361 , PMID:30466619 monocrotaline multiple interactions ISO RGD:3186 6480464 4-chlorobenzyltetrahydroberberine inhibits the reaction [Monocrotaline results in decreased activity of NOS3 protein] more ... CTD PMID:16225752 more ... monocrotaline increases expression ISO RGD:3186 6480464 Monocrotaline results in increased expression of NOS3 mRNA CTD PMID:16225752 , PMID:22022327 myricitrin multiple interactions EXP 6480464 myricitrin inhibits the reaction [Hydrogen Peroxide results in decreased activity of NOS3 protein] CTD PMID:23639522 N(gamma)-nitro-L-arginine methyl ester multiple interactions ISO RGD:3186 6480464 Sildenafil Citrate inhibits the reaction [NG-Nitroarginine Methyl Ester results in decreased expression of NOS3 protein], tangeretin inhibits the reaction [NG-Nitroarginine Methyl Ester results in decreased expression of NOS3 protein] CTD PMID:32479886 N(gamma)-nitro-L-arginine methyl ester decreases expression EXP 6480464 NG-Nitroarginine Methyl Ester results in decreased expression of NOS3 protein CTD PMID:28624453 N(gamma)-nitro-L-arginine methyl ester multiple interactions EXP 6480464 [Folic Acid co-treated with NG-Nitroarginine Methyl Ester] results in decreased expression of NOS3 protein CTD PMID:28624453 N(gamma)-nitro-L-arginine methyl ester decreases expression ISO RGD:3186 6480464 NG-Nitroarginine Methyl Ester results in decreased expression of NOS3 protein CTD PMID:32479886 N-acetyl-L-cysteine multiple interactions ISO RGD:3186 6480464 Acetylcysteine inhibits the reaction [Streptozocin results in decreased phosphorylation of NOS3 protein] more ... CTD PMID:16140881 , PMID:21912612 N-acetyl-L-cysteine multiple interactions EXP 6480464 Acetylcysteine inhibits the reaction [Aldrin results in increased expression of NOS3 mRNA] more ... CTD PMID:17026986 more ... N-acetyl-L-cysteine increases expression ISO RGD:3186 6480464 Acetylcysteine results in increased expression of NOS3 protein CTD PMID:17321519 N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal decreases degradation EXP 6480464 benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in decreased degradation of NOS3 protein CTD PMID:20229525 N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal increases expression ISO RGD:10997 6480464 benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased expression of NOS3 protein CTD PMID:20675566 N-desethylamiodarone multiple interactions EXP 6480464 desethylamiodarone promotes the reaction [NOS3 protein results in increased chemical synthesis of Nitric Oxide] CTD PMID:16479044 N-methyl-4-phenylpyridinium affects expression EXP 6480464 1-Methyl-4-phenylpyridinium affects the expression of NOS3 mRNA CTD PMID:12710931 N-nitrosodiethylamine multiple interactions ISO RGD:3186 6480464 Fluorouracil inhibits the reaction [Diethylnitrosamine results in decreased expression of NOS3 mRNA], zolmitriptan inhibits the reaction [Diethylnitrosamine results in decreased expression of NOS3 mRNA] CTD PMID:31129132 N-nitrosodiethylamine decreases expression ISO RGD:3186 6480464 Diethylnitrosamine results in decreased expression of NOS3 mRNA CTD PMID:31129132 N-nitrosodimethylamine decreases expression ISO RGD:3186 6480464 Dimethylnitrosamine results in decreased expression of NOS3 protein CTD PMID:18364076 N-nitrosodimethylamine multiple interactions ISO RGD:3186 6480464 Dimethylnitrosamine promotes the reaction [CAV1 protein binds to NOS3 protein] CTD PMID:18364076 naphthalene multiple interactions EXP 6480464 1 more ... CTD PMID:15183461 naphthalene increases expression EXP 6480464 naphthalene results in increased expression of NOS3 mRNA, naphthalene results in increased expression of NOS3 protein CTD PMID:15183461 nebivolol increases expression ISO RGD:3186 6480464 Nebivolol results in increased expression of NOS3 protein CTD PMID:19962728 nebivolol multiple interactions ISO RGD:3186 6480464 [Nebivolol co-treated with Flutamide] results in increased expression of NOS3 protein CTD PMID:19962728 nebivolol increases expression ISO RGD:10997 6480464 Nebivolol results in increased expression of NOS3 CTD PMID:23886954 nebivolol increases activity EXP 6480464 Nebivolol results in increased activity of NOS3 protein CTD PMID:17977009 nickel atom multiple interactions ISO RGD:10997 6480464 [Particulate Matter co-treated with Nickel] results in decreased expression of [NOS3 protein binds to NOS3 protein] more ... CTD PMID:23788629 nickel atom increases activity ISO RGD:10997 6480464 Nickel results in increased activity of NOS3 protein CTD PMID:12540486 nickel atom multiple interactions EXP 6480464 1 more ... CTD PMID:23788629 nickel dichloride multiple interactions EXP 6480464 nickel chloride inhibits the reaction [fluoranthene results in increased expression of NOS3 protein] more ... CTD PMID:15183461 nicorandil multiple interactions ISO RGD:10997 6480464 Nicorandil inhibits the reaction [Folic Acid results in decreased expression of NOS3 protein] CTD PMID:33404076 nicotine increases expression EXP 6480464 Nicotine results in increased expression of NOS3 mRNA CTD PMID:11166759 nicotinic acid increases expression ISO RGD:10997 6480464 Niacin results in increased expression of NOS3 mRNA CTD PMID:17557352 nicotinic acid increases phosphorylation ISO RGD:3186 6480464 Niacin results in increased phosphorylation of NOS3 protein CTD PMID:17557352 nicotinic acid multiple interactions ISO RGD:3186 6480464 [Niacin co-treated with Chromium] inhibits the reaction [CAV1 protein binds to NOS3 protein], [Niacin co-treated with Chromium] results in increased phosphorylation of NOS3 protein CTD PMID:19027847 nifedipine multiple interactions EXP 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Nifedipine promotes the reaction [[Hydrogen Peroxide co-treated with Simvastatin] results in increased phosphorylation of and results in increased expression of NOS3 protein]] more ... CTD PMID:20562903 nitrates multiple interactions ISO RGD:3186 6480464 [[Uranium results in decreased activity of NOS2 protein] co-treated with [Uranium results in increased activity of NOS3 protein]] results in decreased abundance of Nitrates CTD PMID:17566059 nitric oxide multiple interactions EXP 6480464 1 more ... CTD PMID:12270858 more ... nitric oxide increases chemical synthesis EXP 6480464 NOS3 protein results in increased chemical synthesis of Nitric Oxide CTD PMID:16479044 more ... nitric oxide affects chemical synthesis EXP 6480464 NOS3 protein affects the chemical synthesis of Nitric Oxide CTD PMID:19696404 nitric oxide multiple interactions ISO RGD:10997 6480464 [Bezafibrate results in increased phosphorylation of NOS3 protein] which results in increased abundance of Nitric Oxide more ... CTD PMID:16737683 more ... nitric oxide increases chemical synthesis ISO RGD:3186 6480464 NOS3 protein results in increased chemical synthesis of Nitric Oxide CTD PMID:15207323 nitric oxide decreases expression ISO RGD:3186 6480464 Nitric Oxide deficiency results in decreased expression of NOS3 mRNA, Nitric Oxide deficiency results in decreased expression of NOS3 protein CTD PMID:10445667 more ... nitric oxide affects expression ISO RGD:3186 6480464 Nitric Oxide deficiency affects the expression of NOS3 protein CTD PMID:19631198 nitric oxide multiple interactions ISO RGD:3186 6480464 [Sildenafil Citrate results in increased expression of NOS3 protein] which results in increased secretion of Nitric Oxide more ... CTD PMID:15207323 more ... nitric oxide increases abundance EXP 6480464 NOS3 protein results in increased abundance of Nitric Oxide CTD PMID:19011239 nitric oxide decreases chemical synthesis EXP 6480464 NOS3 gene mutant form results in decreased chemical synthesis of Nitric Oxide CTD PMID:11740345 nitrites multiple interactions EXP 6480464 [NOS3 intron polymorphism co-treated with Methylmercury Compounds] results in decreased abundance of Nitrites CTD PMID:22134029 nitrites multiple interactions ISO RGD:3186 6480464 [[Uranium results in decreased activity of NOS2 protein] co-treated with [Uranium results in increased activity of NOS3 protein]] results in decreased abundance of Nitrites CTD PMID:17566059 nitrofen decreases expression ISO RGD:3186 6480464 nitrofen results in decreased expression of NOS3 mRNA, nitrofen results in decreased expression of NOS3 protein CTD PMID:20638522 more ... nitrofen increases expression ISO RGD:3186 6480464 nitrofen results in increased expression of NOS3 mRNA, nitrofen results in increased expression of NOS3 protein CTD PMID:15756563 , PMID:25078423 nitrogen dioxide multiple interactions ISO RGD:10997 6480464 [Particulate Matter co-treated with Sulfur Dioxide co-treated with Nitrogen Dioxide] results in decreased expression of NOS3 protein CTD PMID:30090456 nitroglycerin multiple interactions ISO RGD:3186 6480464 [Nitroglycerin co-treated with Hemin] results in increased expression of NOS3 mRNA, Nitroglycerin promotes the reaction [[Calcimycin results in increased activity of NOS3 protein] which results in increased abundance of Superoxides] CTD PMID:10625313 , PMID:17541025 nitroglycerin increases expression ISO RGD:3186 6480464 Nitroglycerin results in increased expression of NOS3 mRNA, Nitroglycerin results in increased expression of NOS3 protein CTD PMID:10625313 more ... nitroprusside multiple interactions EXP 6480464 Nitroprusside inhibits the reaction [Glucose deficiency results in decreased expression of NOS3 protein] CTD PMID:17855661 notoginsenoside R1 multiple interactions ISO RGD:10997 6480464 notoginsenoside R1 inhibits the reaction [Lipopolysaccharides results in decreased expression of NOS3 protein] CTD PMID:23170834 oleic acid decreases expression EXP 6480464 Oleic Acid results in decreased expression of NOS3 mRNA CTD PMID:16895544 olmesartan multiple interactions ISO RGD:3186 6480464 olmesartan promotes the reaction [NOS3 protein binds to NOS3 protein] more ... CTD PMID:17170375 orotic acid multiple interactions EXP 6480464 [Orotic Acid inhibits the reaction [INS protein results in increased phosphorylation of NOS3 protein]] which results in decreased abundance of Nitric Oxide more ... CTD PMID:25601987 orphenadrine affects expression ISO RGD:3186 6480464 Orphenadrine affects the expression of NOS3 mRNA CTD PMID:23665939 Osajin increases expression EXP 6480464 osajin results in increased expression of NOS3 mRNA CTD PMID:20706672 ouabain multiple interactions ISO RGD:3186 6480464 5-(dimethylamino)-N-(3, 4-dimethyl-5-isoxazolyl)-1-naphthalenesulfonamide inhibits the reaction [Ouabain results in increased expression of NOS3 protein] CTD PMID:15477225 ouabain affects expression ISO RGD:3186 6480464 Ouabain affects the expression of NOS3 protein CTD PMID:12384489 ouabain increases expression ISO RGD:3186 6480464 Ouabain results in increased expression of NOS3 protein CTD PMID:15477225 ozone increases expression ISO RGD:3186 6480464 Ozone results in increased expression of NOS3 mRNA CTD PMID:16081523 , PMID:20980218 paclitaxel decreases expression EXP 6480464 Paclitaxel results in decreased expression of NOS3 mRNA, Paclitaxel results in decreased expression of NOS3 protein CTD PMID:19520256 , PMID:19815708 paclitaxel multiple interactions EXP 6480464 Aspirin inhibits the reaction [Paclitaxel results in decreased expression of NOS3 protein], cilostazol inhibits the reaction [Paclitaxel results in decreased expression of NOS3 protein] CTD PMID:19520256 palytoxin increases expression EXP 6480464 palytoxin results in increased expression of NOS3 mRNA CTD PMID:23142474 paracetamol affects expression ISO RGD:10997 6480464 Acetaminophen affects the expression of NOS3 mRNA CTD PMID:17562736 paracetamol multiple interactions ISO RGD:3186 6480464 Acetaminophen inhibits the reaction [Arsenic results in decreased expression of NOS3 mRNA] CTD PMID:22120977 paracetamol multiple interactions ISO RGD:10997 6480464 Semaxinib inhibits the reaction [Acetaminophen results in increased expression of NOS3 protein] CTD PMID:16565415 paracetamol decreases expression ISO RGD:3186 6480464 Acetaminophen results in decreased expression of NOS3 mRNA CTD PMID:16172162 paracetamol increases expression ISO RGD:10997 6480464 Acetaminophen results in increased expression of NOS3 protein CTD PMID:16565415 paraquat increases expression ISO RGD:3186 6480464 Paraquat results in increased expression of NOS3 mRNA, Paraquat results in increased expression of NOS3 protein CTD PMID:20388547 paricalcitol increases expression ISO RGD:10997 6480464 paricalcitol results in increased expression of NOS3 protein CTD PMID:20720404 , PMID:25037058 paricalcitol multiple interactions ISO RGD:10997 6480464 [paricalcitol co-treated with Enalapril] results in increased expression of NOS3 protein CTD PMID:20720404 PD123319 multiple interactions EXP 6480464 [PD 123319 binds to and results in decreased activity of AGTR2 protein] inhibits the reaction [candesartan results in increased expression of NOS3 protein] CTD PMID:18551021 pentaerythritol tetranitrate increases expression ISO RGD:3186 6480464 Pentaerythritol Tetranitrate results in increased expression of NOS3 protein CTD PMID:17541025 perfluorooctane-1-sulfonic acid increases expression EXP 6480464 perfluorooctane sulfonic acid results in increased expression of NOS3 mRNA CTD PMID:22269386 perfluorooctane-1-sulfonic acid multiple interactions ISO RGD:10997 6480464 [perfluorooctane sulfonic acid co-treated with Pectins] results in decreased expression of NOS3 mRNA CTD PMID:36331819 perfluorooctane-1-sulfonic acid decreases expression EXP 6480464 perfluorooctane sulfonic acid results in decreased expression of NOS3 mRNA CTD PMID:32790152 perfluorooctane-1-sulfonic acid multiple interactions ISO RGD:3186 6480464 perfluorooctane sulfonic acid results in decreased expression of and results in decreased phosphorylation of NOS3 protein CTD PMID:32980420 perfluorooctanoic acid decreases expression EXP 6480464 perfluorooctanoic acid results in decreased expression of NOS3 mRNA CTD PMID:32790152 peroxynitrous acid multiple interactions EXP 6480464 Peroxynitrous Acid results in increased nitrosation of and results in decreased activity of NOS3 protein, SOD1 protein inhibits the reaction [[spermine nitric oxide complex results in increased abundance of Peroxynitrous Acid] which results in increased metabolism of NOS3 protein] CTD PMID:11509453 , PMID:12489993 phenylarsine oxide affects localization EXP 6480464 oxophenylarsine affects the localization of NOS3 protein CTD PMID:9546377 phenylephrine affects response to substance ISO RGD:10997 6480464 NOS3 protein affects the susceptibility to Phenylephrine CTD PMID:17403420 phenylephrine decreases response to substance ISO RGD:3186 6480464 NOS3 protein results in decreased susceptibility to Phenylephrine CTD PMID:10954898 phenylephrine multiple interactions ISO RGD:3186 6480464 NOS3 protein results in increased susceptibility to [Acetylcholine co-treated with Phenylephrine] CTD PMID:10954898 phenylephrine increases expression ISO RGD:3186 6480464 Phenylephrine results in increased expression of NOS3 mRNA, Phenylephrine results in increased expression of NOS3 protein CTD PMID:15753950 phenylephrine affects response to substance ISO RGD:3186 6480464 NOS3 protein affects the susceptibility to Phenylephrine CTD PMID:11504159 phenylephrine decreases response to substance ISO RGD:10997 6480464 NOS3 protein results in decreased susceptibility to Phenylephrine CTD PMID:15381055 phloretin decreases expression EXP 6480464 Phloretin results in decreased expression of NOS3 mRNA CTD PMID:20021702 phloretin multiple interactions EXP 6480464 Phloretin inhibits the reaction [Hydrogen Peroxide results in increased expression of NOS3 mRNA] CTD PMID:20021702 phlorizin multiple interactions EXP 6480464 Phlorhizin inhibits the reaction [Hydrogen Peroxide results in increased expression of NOS3 mRNA] CTD PMID:20021702 phlorizin decreases expression EXP 6480464 Phlorhizin results in decreased expression of NOS3 mRNA CTD PMID:20021702 phorbol 13-acetate 12-myristate increases expression ISO RGD:10997 6480464 Tetradecanoylphorbol Acetate results in increased expression of NOS3 protein CTD PMID:31351099 phorbol 13-acetate 12-myristate multiple interactions ISO RGD:10997 6480464 decursin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of NOS3 protein] CTD PMID:31351099 phosphane increases expression ISO RGD:3186 6480464 phosphine results in increased expression of NOS3 mRNA CTD PMID:34427094 picoxystrobin affects expression EXP 6480464 picoxystrobin affects the expression of NOS3 mRNA CTD PMID:34642769 pioglitazone multiple interactions ISO RGD:3186 6480464 Pioglitazone inhibits the reaction [[Dietary Fats co-treated with Fructose] results in decreased expression of NOS3 protein] CTD PMID:30343038 pirinixic acid multiple interactions ISO RGD:3186 6480464 pirinixic acid results in increased expression of and results in increased phosphorylation of NOS3 protein CTD PMID:19151258 plerixafor multiple interactions EXP 6480464 plerixafor inhibits the reaction [CXCL12 protein results in increased phosphorylation of NOS3 protein] CTD PMID:18660423 Pomiferin increases expression EXP 6480464 pomiferin results in increased expression of NOS3 mRNA CTD PMID:20706672 potassium chloride multiple interactions ISO RGD:3186 6480464 [19-oxo-11-deoxycorticosterone acetate co-treated with Potassium Chloride co-treated with Sodium Chloride] results in decreased expression of NOS3 protein, atrasentan inhibits the reaction [[19-oxo-11-deoxycorticosterone acetate co-treated with Potassium Chloride co-treated with Sodium Chloride] results in decreased expression of NOS3 protein] CTD PMID:18823320 potassium chloride decreases response to substance ISO RGD:10997 6480464 NOS3 protein results in decreased susceptibility to Potassium Chloride CTD PMID:15381055 pravastatin multiple interactions ISO RGD:3186 6480464 [resveratrol co-treated with Pravastatin] results in increased phosphorylation of NOS3 protein more ... CTD PMID:17170375 , PMID:17188708 pravastatin increases phosphorylation ISO RGD:3186 6480464 Pravastatin results in increased phosphorylation of NOS3 protein CTD PMID:17188708 procymidone decreases expression ISO RGD:3186 6480464 procymidone results in decreased expression of NOS3 mRNA CTD PMID:15686871 progesterone multiple interactions EXP 6480464 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Progesterone promotes the reaction [Estradiol results in increased activity of NOS3 protein]] more ... CTD PMID:15358673 , PMID:18710710 progesterone decreases expression EXP 6480464 Progesterone results in decreased expression of NOS3 protein CTD PMID:21558462 progesterone increases expression ISO RGD:3186 6480464 Progesterone results in increased expression of NOS3 protein CTD PMID:15358673 progesterone increases activity ISO RGD:3186 6480464 Progesterone results in increased activity of NOS3 protein CTD PMID:15358673 progesterone increases phosphorylation EXP 6480464 Progesterone results in increased phosphorylation of NOS3 protein CTD PMID:15358673 progesterone increases expression EXP 6480464 Progesterone results in increased expression of NOS3 mRNA, Progesterone results in increased expression of NOS3 protein CTD PMID:15358673 , PMID:18710710 progesterone increases activity EXP 6480464 Progesterone results in increased activity of NOS3 protein CTD PMID:15358673 propazine multiple interactions EXP 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [propazine results in decreased expression of NOS3 protein], U 0126 inhibits the reaction [propazine results in decreased expression of NOS3 protein] CTD PMID:27431321 propazine decreases expression EXP 6480464 propazine results in decreased expression of NOS3 protein CTD PMID:27431321 propranolol affects expression ISO RGD:3186 6480464 Propranolol affects the expression of NOS3 CTD PMID:10889169 protoporphyrin decreases expression EXP 6480464 protoporphyrin IX results in decreased expression of NOS3 protein CTD PMID:23624237 puerarin multiple interactions ISO RGD:10997 6480464 puerarin inhibits the reaction [lead acetate results in decreased expression of NOS3 protein] CTD PMID:23501611 puerarin increases phosphorylation EXP 6480464 puerarin results in increased phosphorylation of NOS3 protein CTD PMID:21884717 puerarin increases expression EXP 6480464 puerarin results in increased expression of NOS3 mRNA CTD PMID:20706672 puerarin increases activity EXP 6480464 puerarin results in increased activity of NOS3 protein CTD PMID:21884717 puerarin multiple interactions EXP 6480464 1 more ... CTD PMID:21884717 quercetin multiple interactions EXP 6480464 Quercetin inhibits the reaction [Hydrogen Peroxide results in decreased expression of NOS3 protein] more ... CTD PMID:16891912 more ... quercetin increases expression ISO RGD:3186 6480464 Quercetin results in increased expression of NOS3 protein CTD PMID:18551111 , PMID:22557973 quercetin multiple interactions ISO RGD:3186 6480464 [chelerythrine co-treated with tyrphostin 47] inhibits the reaction [Quercetin results in increased expression of NOS3 protein] more ... CTD PMID:16226777 more ... quercetin increases expression EXP 6480464 Quercetin results in increased expression of NOS3 mRNA CTD PMID:20021702 , PMID:21632981 quercetin decreases expression ISO RGD:3186 6480464 Quercetin results in decreased expression of NOS3 protein CTD PMID:16331104 quercetin multiple interactions ISO RGD:10997 6480464 [3 more ... CTD PMID:17135264 more ... quercetin decreases expression EXP 6480464 Quercetin results in decreased expression of NOS3 mRNA CTD PMID:15740983 quinapril hydrochloride affects expression ISO RGD:3186 6480464 Quinapril affects the expression of NOS3 mRNA CTD PMID:12176110 rac-lactic acid affects transport EXP 6480464 NOS3 protein affects the transport of Lactic Acid CTD PMID:16032374 raloxifene increases expression ISO RGD:3186 6480464 Raloxifene Hydrochloride results in increased expression of NOS3 mRNA CTD PMID:11779577 ramipril multiple interactions ISO RGD:10997 6480464 NOS3 protein affects the reaction [Ramipril results in increased abundance of Cyclic GMP] CTD PMID:16891913 reactive oxygen species multiple interactions ISO RGD:10997 6480464 NOS3 protein affects the reaction [Doxorubicin results in increased abundance of Reactive Oxygen Species] CTD PMID:17638931 resveratrol multiple interactions ISO RGD:3186 6480464 [Resveratrol co-treated with Fructose] results in increased expression of NOS3 mRNA more ... CTD PMID:17188708 more ... resveratrol increases activity EXP 6480464 resveratrol results in increased activity of NOS3 protein CTD PMID:17278969 more ... resveratrol increases expression EXP 6480464 resveratrol results in increased expression of NOS3 mRNA, resveratrol results in increased expression of NOS3 protein CTD PMID:15740983 more ... resveratrol affects phosphorylation EXP 6480464 resveratrol affects the phosphorylation of NOS3 protein CTD PMID:25198200 resveratrol increases expression ISO RGD:3186 6480464 resveratrol results in increased expression of NOS3 mRNA, resveratrol results in increased expression of NOS3 protein CTD PMID:14990356 more ... resveratrol decreases expression EXP 6480464 resveratrol results in decreased expression of NOS3 mRNA, resveratrol results in decreased expression of NOS3 protein CTD PMID:16775512 , PMID:20878097 resveratrol multiple interactions ISO RGD:10997 6480464 [resveratrol results in increased expression of NOS3 protein] which results in increased chemical synthesis of Nitric Oxide more ... CTD PMID:20675566 more ... resveratrol increases phosphorylation ISO RGD:10997 6480464 resveratrol results in increased phosphorylation of NOS3 protein CTD PMID:19478208 resveratrol affects activity ISO RGD:10997 6480464 resveratrol deficiency affects the activity of NOS3 protein CTD PMID:20610621 resveratrol increases response to substance ISO RGD:10997 6480464 NOS3 protein results in increased susceptibility to resveratrol CTD PMID:22552115 resveratrol increases phosphorylation EXP 6480464 resveratrol results in increased phosphorylation of NOS3 protein CTD PMID:17499741 , PMID:23463510 resveratrol increases phosphorylation ISO RGD:3186 6480464 resveratrol results in increased phosphorylation of NOS3 protein CTD PMID:17188708 resveratrol affects localization EXP 6480464 resveratrol affects the localization of NOS3 protein CTD PMID:16759640 resveratrol increases expression ISO RGD:10997 6480464 resveratrol analog results in increased expression of NOS3 mRNA more ... CTD PMID:19066340 more ... resveratrol multiple interactions EXP 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [[Resveratrol results in increased phosphorylation of and results in increased activity of NOS3 protein] which results in increased abundance of Nitric Oxide] more ... CTD PMID:12270858 more ... ritonavir decreases expression EXP 6480464 Ritonavir results in decreased expression of NOS3 mRNA CTD PMID:22037733 ritonavir multiple interactions EXP 6480464 Masoprocol inhibits the reaction [Ritonavir results in decreased expression of NOS3 mRNA] CTD PMID:22037733 Rosavin increases expression EXP 6480464 rosavin results in increased expression of NOS3 mRNA CTD PMID:20706672 rosmarinic acid decreases expression ISO RGD:3186 6480464 rosmarinic acid results in decreased expression of NOS3 protein CTD PMID:25455894 rosuvastatin calcium multiple interactions EXP 6480464 Rosuvastatin Calcium inhibits the reaction [CRP protein results in decreased expression of NOS3], Rosuvastatin Calcium results in increased phosphorylation of and results in increased activity of NOS3 protein CTD PMID:18162361 , PMID:21562509 rosuvastatin calcium affects response to substance ISO RGD:10997 6480464 NOS3 protein affects the susceptibility to Rosuvastatin Calcium CTD PMID:12354446 rosuvastatin calcium increases expression ISO RGD:3186 6480464 Rosuvastatin Calcium results in increased expression of NOS3 mRNA CTD PMID:15681303 rosuvastatin calcium increases expression ISO RGD:10997 6480464 Rosuvastatin Calcium results in increased expression of NOS3 mRNA CTD PMID:12354446 rotenone multiple interactions EXP 6480464 Rotenone inhibits the reaction [Equol results in increased phosphorylation of and results in increased activity of NOS3 protein] CTD PMID:21300668 rotenone increases expression EXP 6480464 Rotenone results in increased expression of NOS3 mRNA CTD PMID:34642769 rotenone affects response to substance EXP 6480464 NOS3 protein affects the susceptibility to Rotenone CTD PMID:34642769 roxarsone multiple interactions EXP 6480464 Roxarsone results in increased phosphorylation of and results in increased activity of NOS3 protein CTD PMID:18414637 salicylic acid multiple interactions ISO RGD:3186 6480464 Salicylic Acid inhibits the reaction [Palmitic Acid inhibits the reaction [Acetylcholine results in increased phosphorylation of NOS3 protein]] CTD PMID:25108154 salsalate multiple interactions ISO RGD:3186 6480464 salicylsalicylic acid affects the expression of and affects the phosphorylation of NOS3 protein CTD PMID:20876710 sapropterin increases activity EXP 6480464 sapropterin results in increased activity of NOS3 protein CTD PMID:23753407 sapropterin multiple interactions EXP 6480464 sapropterin deficiency inhibits the reaction [NOS3 protein results in increased abundance of Superoxides], sapropterin deficiency promotes the reaction [NOS3 protein results in increased abundance of Superoxides] CTD PMID:19011239 sapropterin multiple interactions ISO RGD:10997 6480464 [NOS3 protein co-treated with sapropterin deficiency] results in increased chemical synthesis of Superoxides, EPO protein inhibits the reaction [[NOS3 protein co-treated with sapropterin deficiency] results in increased chemical synthesis of Superoxides] CTD PMID:25490417 sarpogrelate multiple interactions ISO RGD:3186 6480464 sarpogrelate promotes the reaction [Oxygen deficiency results in increased expression of NOS3 protein] CTD PMID:25931318 SB 203580 multiple interactions EXP 6480464 SB 203580 inhibits the reaction [arsenite results in increased phosphorylation of and results in increased activity of NOS3 protein] CTD PMID:11788791 scutellarin increases expression ISO RGD:3186 6480464 scutellarin results in increased expression of NOS3 protein CTD PMID:16297343 selenium atom increases expression ISO RGD:10997 6480464 Selenium results in increased expression of NOS3 mRNA CTD PMID:28810182 sepiapterin increases activity EXP 6480464 sepiapterin results in increased activity of NOS3 protein CTD PMID:11243424 sibutramine multiple interactions EXP 6480464 sibutramine results in decreased expression of and affects the phosphorylation of NOS3 protein CTD PMID:27838152 sildenafil citrate increases activity ISO RGD:10997 6480464 Sildenafil Citrate results in increased activity of NOS3 protein CTD PMID:23650378 sildenafil citrate increases phosphorylation ISO RGD:3186 6480464 Sildenafil Citrate results in increased phosphorylation of NOS3 protein CTD PMID:18373738 sildenafil citrate increases expression ISO RGD:3186 6480464 Sildenafil Citrate results in increased expression of NOS3 protein CTD PMID:19845545 sildenafil citrate multiple interactions ISO RGD:3186 6480464 [Cisplatin co-treated with Sildenafil Citrate] results in increased expression of NOS3 mRNA more ... CTD PMID:19152827 more ... silver atom multiple interactions ISO RGD:3186 6480464 Silver results in increased phosphorylation of and results in increased activity of NOS3 protein CTD PMID:19800954 silver(0) multiple interactions ISO RGD:3186 6480464 Silver results in increased phosphorylation of and results in increased activity of NOS3 protein CTD PMID:19800954 simazine decreases expression ISO RGD:10997 6480464 Simazine results in decreased expression of NOS3 mRNA, Simazine results in decreased expression of NOS3 protein CTD PMID:22984576 , PMID:27431321 simazine multiple interactions EXP 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Simazine results in decreased expression of NOS3 protein], U 0126 inhibits the reaction [Simazine results in decreased expression of NOS3 protein] CTD PMID:27431321 simazine decreases expression EXP 6480464 Simazine results in decreased expression of NOS3 mRNA, Simazine results in decreased expression of NOS3 protein CTD PMID:27431321 simvastatin increases expression EXP 6480464 Simvastatin results in increased expression of NOS3 more ... CTD PMID:16002570 more ... simvastatin increases expression ISO RGD:3186 6480464 Simvastatin results in increased expression of NOS3 more ... CTD PMID:10188333 more ... simvastatin decreases expression ISO RGD:3186 6480464 Simvastatin results in decreased expression of NOS3 mRNA, Simvastatin results in decreased expression of NOS3 protein CTD PMID:16414398 , PMID:21968084 simvastatin decreases expression ISO RGD:10997 6480464 Simvastatin results in decreased expression of NOS3 mRNA CTD PMID:11947894 simvastatin increases expression ISO RGD:10997 6480464 Simvastatin results in increased expression of NOS3 protein CTD PMID:15572054 simvastatin multiple interactions EXP 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Nifedipine promotes the reaction [[Hydrogen Peroxide co-treated with Simvastatin] results in increased phosphorylation of and results in increased expression of NOS3 protein]] more ... CTD PMID:20493886 , PMID:20562903 simvastatin increases phosphorylation ISO RGD:3186 6480464 Simvastatin results in increased phosphorylation of NOS3 protein CTD PMID:18826357 simvastatin multiple interactions ISO RGD:3186 6480464 Nitroarginine inhibits the reaction [Simvastatin inhibits the reaction [Cyclophosphamide results in decreased expression of NOS3 protein]] more ... CTD PMID:16002570 more ... sirolimus multiple interactions EXP 6480464 Aspirin inhibits the reaction [Sirolimus results in decreased expression of NOS3 protein], cilostazol inhibits the reaction [Sirolimus results in decreased expression of NOS3 protein] CTD PMID:19520256 sirolimus increases phosphorylation ISO RGD:10997 6480464 Sirolimus results in increased phosphorylation of NOS3 protein CTD PMID:17261647 sirolimus decreases expression EXP 6480464 Sirolimus results in decreased expression of NOS3 mRNA, Sirolimus results in decreased expression of NOS3 protein CTD PMID:19520256 , PMID:19815708 SKF-96365 hydrochloride multiple interactions EXP 6480464 1-(2-(3-(4-methoxyphenyl)propoxy)-4-methoxyphenylethyl)-1H-imidazole inhibits the reaction [fluoranthene results in increased expression of NOS3 protein] more ... CTD PMID:15183461 sodium arsenite increases expression EXP 6480464 sodium arsenite results in increased expression of NOS3 mRNA, sodium arsenite results in increased expression of NOS3 protein CTD PMID:12703962 sodium arsenite increases expression ISO RGD:3186 6480464 sodium arsenite results in increased expression of NOS3 protein CTD PMID:25218292 sodium arsenite decreases expression ISO RGD:3186 6480464 sodium arsenite results in decreased expression of NOS3 mRNA CTD PMID:25058445 sodium arsenite multiple interactions ISO RGD:3186 6480464 [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of NOS3 protein more ... CTD PMID:25058445 more ... sodium arsenite decreases response to substance ISO RGD:10997 6480464 NOS3 results in decreased susceptibility to sodium arsenite CTD PMID:16239170 sodium atom increases expression ISO RGD:3186 6480464 Sodium results in increased expression of NOS3 protein CTD PMID:16344378 sodium atom increases phosphorylation ISO RGD:3186 6480464 Sodium results in increased phosphorylation of NOS3 protein CTD PMID:16344378 sodium atom decreases phosphorylation ISO RGD:3186 6480464 Sodium results in decreased phosphorylation of NOS3 protein CTD PMID:16344378 sodium azide multiple interactions EXP 6480464 Sodium Azide inhibits the reaction [2-butylamino-2-demethoxy-hypocrellin B results in increased expression of NOS3 mRNA], Sodium Azide inhibits the reaction [2-butylamino-2-demethoxy-hypocrellin B results in increased expression of NOS3 protein] CTD PMID:17045927 sodium chloride decreases expression ISO RGD:3186 6480464 Sodium Chloride results in decreased expression of NOS3 protein CTD PMID:20232302 sodium chloride multiple interactions ISO RGD:3186 6480464 [19-oxo-11-deoxycorticosterone acetate co-treated with Potassium Chloride co-treated with Sodium Chloride] results in decreased expression of NOS3 protein more ... CTD PMID:18823320 , PMID:20232302 sodium nitrate multiple interactions ISO RGD:10997 6480464 sodium nitrate inhibits the reaction [NOS3 gene mutant form results in increased abundance of Triglycerides] CTD PMID:20876122 Sodium salicylate multiple interactions EXP 6480464 Sodium Salicylate inhibits the reaction [Palmitates inhibits the reaction [INS protein results in increased phosphorylation of NOS3 protein]] CTD PMID:23504962 Sodium salicylate increases phosphorylation ISO RGD:10997 6480464 Sodium Salicylate results in increased phosphorylation of NOS3 protein CTD PMID:21303813 Soman increases expression ISO RGD:3186 6480464 Soman results in increased expression of NOS3 mRNA CTD PMID:19281266 sorafenib decreases expression ISO RGD:3186 6480464 Sorafenib results in decreased expression of NOS3 mRNA CTD PMID:33503445 stilbenoid multiple interactions EXP 6480464 Stilbenes inhibits the reaction [[Hydrogen Peroxide results in decreased activity of NOS3 protein] which results in decreased chemical synthesis of Nitric Oxide] CTD PMID:22358095 streptozocin multiple interactions ISO RGD:3186 6480464 1 more ... CTD PMID:11696579 more ... streptozocin decreases phosphorylation ISO RGD:3186 6480464 Streptozocin results in decreased phosphorylation of NOS3 protein CTD PMID:18266981 more ... streptozocin decreases expression ISO RGD:3186 6480464 Streptozocin results in decreased expression of NOS3 mRNA, Streptozocin results in decreased expression of NOS3 protein CTD PMID:16045816 more ... streptozocin increases expression ISO RGD:3186 6480464 Streptozocin results in increased expression of NOS3 mRNA, Streptozocin results in increased expression of NOS3 protein CTD PMID:12377873 more ... sucrose multiple interactions ISO RGD:3186 6480464 Chromium inhibits the reaction [Sucrose results in decreased expression of NOS3 protein] CTD PMID:17215582 sucrose decreases expression ISO RGD:3186 6480464 Sucrose results in decreased expression of NOS3 protein CTD PMID:17215582 sulfur dioxide multiple interactions ISO RGD:10997 6480464 [Particulate Matter co-treated with Sulfur Dioxide co-treated with Nitrogen Dioxide] results in decreased expression of NOS3 protein CTD PMID:30090456 superoxide multiple interactions EXP 6480464 7 more ... CTD PMID:19011239 , PMID:21300668 superoxide affects chemical synthesis EXP 6480464 NOS3 protein affects the chemical synthesis of Superoxides CTD PMID:19696404 superoxide decreases abundance ISO RGD:3186 6480464 NOS3 protein results in decreased abundance of Superoxides CTD PMID:18714161 superoxide multiple interactions ISO RGD:10997 6480464 [NOS3 protein co-treated with sapropterin deficiency] results in increased chemical synthesis of Superoxides more ... CTD PMID:17272743 , PMID:25490417 superoxide multiple interactions ISO RGD:3186 6480464 [Calcimycin results in increased activity of NOS3 protein] which results in increased abundance of Superoxides more ... CTD PMID:10625313 , PMID:20977430 superoxide increases abundance EXP 6480464 NOS3 protein results in increased abundance of Superoxides CTD PMID:19011239 T-2 toxin decreases expression ISO RGD:10997 6480464 T-2 Toxin results in decreased expression of NOS3 mRNA CTD PMID:22960706 tacrolimus hydrate increases expression EXP 6480464 Tacrolimus results in increased expression of NOS3 mRNA CTD PMID:12352326 tacrolimus hydrate decreases expression ISO RGD:3186 6480464 Tacrolimus results in decreased expression of NOS3 mRNA CTD PMID:9931093 tacrolimus hydrate decreases activity ISO RGD:3186 6480464 Tacrolimus results in decreased activity of NOS3 protein CTD PMID:9931093 tamoxifen multiple interactions ISO RGD:10997 6480464 Tamoxifen inhibits the reaction [Estradiol results in increased expression of NOS3 mRNA] CTD PMID:17873880 tangeretin multiple interactions ISO RGD:3186 6480464 tangeretin inhibits the reaction [NG-Nitroarginine Methyl Ester results in decreased expression of NOS3 protein] CTD PMID:32479886 Tanshinone I increases expression EXP 6480464 tanshinone results in increased expression of NOS3 mRNA CTD PMID:15849732 Tanshinone I multiple interactions ISO RGD:3186 6480464 tanshinone inhibits the reaction [Oxygen deficiency results in decreased expression of NOS3 protein] CTD PMID:28985491 tebufenpyrad increases expression EXP 6480464 4-chloro-N-((4-(1, 1-dimethylethyl)phenyl)methyl)-3-ethyl-1-methyl-1H-pyrazole-5-carboxamide results in increased expression of NOS3 mRNA CTD PMID:34642769 telmisartan multiple interactions ISO RGD:10997 6480464 2-chloro-5-nitrobenzanilide inhibits the reaction [telmisartan results in increased expression of NOS3 protein], 2-chloro-5-nitrobenzanilide inhibits the reaction [telmisartan results in increased phosphorylation of NOS3 protein] CTD PMID:21156825 telmisartan increases phosphorylation ISO RGD:10997 6480464 telmisartan results in increased phosphorylation of NOS3 protein CTD PMID:21156825 telmisartan increases expression ISO RGD:10997 6480464 telmisartan results in increased expression of NOS3 protein CTD PMID:21156825 tenofovir disoproxil fumarate multiple interactions EXP 6480464 coenzyme Q10 inhibits the reaction [Tenofovir results in decreased phosphorylation of NOS3 protein] CTD PMID:23640862 tenofovir disoproxil fumarate decreases phosphorylation EXP 6480464 Tenofovir results in decreased phosphorylation of NOS3 protein CTD PMID:23640862 terbutylazine multiple interactions EXP 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [terbutylazine results in decreased expression of NOS3 protein], U 0126 inhibits the reaction [terbutylazine results in decreased expression of NOS3 protein] CTD PMID:27431321 terbutylazine decreases expression EXP 6480464 terbutylazine results in decreased expression of NOS3 protein CTD PMID:27431321 testosterone increases expression EXP 6480464 Testosterone results in increased expression of NOS3 protein CTD PMID:21688280 , PMID:21843929 testosterone affects expression ISO RGD:3186 6480464 Testosterone affects the expression of NOS3 mRNA CTD PMID:22028410 tetrachloromethane increases expression ISO RGD:3186 6480464 Carbon Tetrachloride results in increased expression of NOS3 mRNA, Carbon Tetrachloride results in increased expression of NOS3 protein CTD PMID:16325526 , PMID:16644059 tetrachloromethane decreases phosphorylation ISO RGD:3186 6480464 Carbon Tetrachloride results in decreased phosphorylation of NOS3 protein CTD PMID:12891555 tetrachloromethane decreases expression ISO RGD:3186 6480464 Carbon Tetrachloride results in decreased expression of NOS3 protein CTD PMID:12575897 tetrachloromethane decreases activity ISO RGD:3186 6480464 Carbon Tetrachloride results in decreased activity of NOS3 protein CTD PMID:12943827 tetrachloromethane multiple interactions ISO RGD:3186 6480464 AKT1 protein inhibits the reaction [Carbon Tetrachloride results in decreased phosphorylation of NOS3 protein] more ... CTD PMID:12891555 more ... tetrachloromethane decreases expression ISO RGD:10997 6480464 Carbon Tetrachloride results in decreased expression of NOS3 mRNA, Carbon Tetrachloride results in decreased expression of NOS3 protein CTD PMID:18429990 tetrahydrocurcumin multiple interactions ISO RGD:10997 6480464 tetrahydrocurcumin inhibits the reaction [Cadmium Chloride results in decreased expression of NOS3 protein] CTD PMID:25502771 tetramethylpyrazine multiple interactions EXP 6480464 DDAH2 promotes the reaction [tetramethylpyrazine inhibits the reaction [Iron-Dextran Complex results in decreased phosphorylation of NOS3 protein]], tetramethylpyrazine inhibits the reaction [Iron-Dextran Complex results in decreased phosphorylation of NOS3 protein] CTD PMID:32135237 theaflavin multiple interactions ISO RGD:10997 6480464 theaflavin inhibits the reaction [APOE gene mutant form results in decreased activity of NOS3 protein] CTD PMID:20093625 thioacetamide multiple interactions ISO RGD:3186 6480464 Thioacetamide promotes the reaction [NOS3 protein results in increased chemical synthesis of Nitric Oxide] CTD PMID:15207323 thioacetamide increases expression ISO RGD:3186 6480464 Thioacetamide results in increased expression of NOS3 mRNA, Thioacetamide results in increased expression of NOS3 protein CTD PMID:15207323 more ... thymoquinone multiple interactions ISO RGD:3186 6480464 thymoquinone inhibits the reaction [Isoproterenol results in increased expression of NOS3 protein] CTD PMID:35940283 Tiron multiple interactions EXP 6480464 1 more ... CTD PMID:23788629 titanium dioxide decreases expression ISO RGD:3186 6480464 titanium dioxide results in decreased expression of NOS3 mRNA CTD PMID:30012374 titanium dioxide multiple interactions ISO RGD:10997 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of NOS3 mRNA CTD PMID:29950665 toluene affects expression ISO RGD:3186 6480464 Toluene affects the expression of NOS3 mRNA CTD PMID:21827849 toluene increases expression ISO RGD:3186 6480464 Toluene results in increased expression of NOS3 mRNA CTD PMID:22967744 toluene 2,4-diisocyanate increases expression EXP 6480464 Toluene 2, 4-Diisocyanate results in increased expression of NOS3 protein CTD PMID:12974195 torcetrapib decreases expression ISO RGD:3186 6480464 torcetrapib results in decreased expression of NOS3 mRNA, torcetrapib results in decreased expression of NOS3 protein CTD PMID:21920972 torcetrapib decreases expression EXP 6480464 torcetrapib results in decreased expression of NOS3 protein CTD PMID:21920972 trans-caffeic acid increases expression EXP 6480464 caffeic acid results in increased expression of NOS3 mRNA CTD PMID:15740983 trans-cinnamic acid increases expression EXP 6480464 cinnamic acid results in increased expression of NOS3 mRNA CTD PMID:15740983 tributylstannane decreases expression ISO RGD:3186 6480464 tributyltin results in decreased expression of NOS3 protein CTD PMID:26873547 tributylstannane multiple interactions ISO RGD:3186 6480464 tributyltin results in decreased expression of and results in increased phosphorylation of NOS3 protein CTD PMID:34902535 trichloroethene increases activity EXP 6480464 Trichloroethylene results in increased activity of NOS3 protein CTD PMID:17719164 trichloroethene decreases expression ISO RGD:10997 6480464 Trichloroethylene results in decreased expression of NOS3 protein CTD PMID:31068537 trichloroethene multiple interactions ISO RGD:10997 6480464 [TEMPOL-H co-treated with Trichloroethylene] results in decreased expression of NOS3 protein CTD PMID:31068537 trichloroethene multiple interactions EXP 6480464 [Trichloroethylene results in increased activity of NOS3 protein] which results in increased chemical synthesis of Nitric Oxide CTD PMID:17719164 trichloroethene increases expression EXP 6480464 Trichloroethylene results in increased expression of NOS3 mRNA CTD PMID:17719164 triclosan multiple interactions ISO RGD:10997 6480464 [Triclosan co-treated with beta-Naphthoflavone] results in decreased expression of NOS3 protein CTD PMID:33722737 trimellitic anhydride decreases expression ISO RGD:10997 6480464 trimellitic anhydride results in decreased expression of NOS3 mRNA CTD PMID:16141432 triptonide increases expression ISO RGD:10997 6480464 triptonide results in increased expression of NOS3 mRNA CTD PMID:33045310 tris(2-butoxyethyl) phosphate affects expression EXP 6480464 tris(2-butoxyethyl) phosphate affects the expression of NOS3 mRNA CTD PMID:29024780 troglitazone increases expression EXP 6480464 troglitazone results in increased expression of NOS3 mRNA, troglitazone results in increased expression of NOS3 protein CTD PMID:16949522 tyrphostin AG 1478 multiple interactions EXP 6480464 [RTKI cpd results in decreased activity of EGFR protein] inhibits the reaction [Equol results in increased phosphorylation of and results in increased activity of NOS3 protein] CTD PMID:21300668 ubiquinones multiple interactions EXP 6480464 Ubiquinone inhibits the reaction [Glycochenodeoxycholic Acid results in decreased expression of NOS3 mRNA] more ... CTD PMID:20020783 udenafil increases expression ISO RGD:3186 6480464 udenafil results in increased expression of NOS3 CTD PMID:21366883 uranium atom multiple interactions ISO RGD:3186 6480464 [[Uranium results in decreased activity of NOS2 protein] co-treated with [Uranium results in increased activity of NOS3 protein]] results in decreased abundance of Nitrates, [[Uranium results in decreased activity of NOS2 protein] co-treated with [Uranium results in increased activity of NOS3 protein]] results in decreased abundance of Nitrites CTD PMID:17566059 uranium atom decreases expression ISO RGD:3186 6480464 Uranium results in decreased expression of NOS3 mRNA CTD PMID:17566059 uranium atom increases activity ISO RGD:3186 6480464 Uranium results in increased activity of NOS3 protein CTD PMID:17566059 urethane multiple interactions ISO RGD:10997 6480464 [Urethane co-treated with Freund's Adjuvant] results in increased expression of NOS3 mRNA CTD PMID:12400877 urethane increases expression ISO RGD:10997 6480464 Urethane results in increased expression of NOS3 mRNA CTD PMID:12400877 ursolic acid multiple interactions ISO RGD:10997 6480464 ursolic acid inhibits the reaction [Choline results in increased expression of NOS3 protein] CTD PMID:27567547 valsartan multiple interactions ISO RGD:3186 6480464 [fluvastatin co-treated with Valsartan] results in increased expression of NOS3 mRNA, Valsartan inhibits the reaction [Oxygen deficiency promotes the reaction [AGT protein results in increased expression of NOS3 protein]] CTD PMID:11897773 , PMID:28951255 valsartan decreases expression ISO RGD:3186 6480464 Valsartan results in decreased expression of NOS3 protein CTD PMID:31023080 valsartan multiple interactions ISO RGD:10997 6480464 Valsartan inhibits the reaction [Oxygen deficiency results in increased phosphorylation of NOS3 protein] CTD PMID:18436887 vanadium atom increases expression EXP 6480464 Vanadium results in increased expression of NOS3 mRNA CTD PMID:19000753 vanadium(0) increases expression EXP 6480464 Vanadium results in increased expression of NOS3 mRNA CTD PMID:19000753 vanillic acid increases expression EXP 6480464 Vanillic Acid results in increased expression of NOS3 mRNA CTD PMID:15740983 vitamin E multiple interactions ISO RGD:3186 6480464 [Vitamin E co-treated with Ascorbic Acid] inhibits the reaction [Dexamethasone results in decreased expression of NOS3 protein], Vitamin E inhibits the reaction [Lead results in increased expression of NOS3 protein] CTD PMID:10523326 , PMID:20068362 vitamin E decreases expression ISO RGD:10997 6480464 Vitamin E results in decreased expression of NOS3 protein CTD PMID:11597945 wortmannin multiple interactions EXP 6480464 Fenofibrate inhibits the reaction [wortmannin results in decreased phosphorylation of NOS3 protein] more ... CTD PMID:11788791 more ... wortmannin multiple interactions ISO RGD:3186 6480464 wortmannin affects the reaction [Carbon Tetrachloride results in increased phosphorylation of and results in increased activity of NOS3 protein] CTD PMID:18317400 wortmannin decreases phosphorylation EXP 6480464 wortmannin results in decreased phosphorylation of NOS3 protein CTD PMID:16442496 Y-27632 increases phosphorylation EXP 6480464 Y 27632 results in increased phosphorylation of NOS3 protein CTD PMID:17322126 Y-27632 multiple interactions EXP 6480464 Mevalonic Acid inhibits the reaction [Y 27632 results in increased phosphorylation of NOS3 protein] CTD PMID:17322126 zidovudine decreases phosphorylation EXP 6480464 Zidovudine results in decreased phosphorylation of NOS3 protein CTD PMID:23640862 zidovudine multiple interactions EXP 6480464 coenzyme Q10 inhibits the reaction [Zidovudine results in decreased phosphorylation of NOS3 protein] CTD PMID:23640862 zinc atom increases expression ISO RGD:3186 6480464 Zinc deficiency results in increased expression of NOS3 CTD PMID:20128680 zinc(0) increases expression ISO RGD:3186 6480464 Zinc deficiency results in increased expression of NOS3 CTD PMID:20128680 zolmitriptan multiple interactions ISO RGD:3186 6480464 zolmitriptan inhibits the reaction [Diethylnitrosamine results in decreased expression of NOS3 mRNA] CTD PMID:31129132
